<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochemistry</journal-id><journal-id journal-id-type="iso-abbrev">Biochemistry</journal-id><journal-id journal-id-type="publisher-id">bi</journal-id><journal-id journal-id-type="coden">bichaw</journal-id><journal-title-group><journal-title>Biochemistry</journal-title></journal-title-group><issn pub-type="ppub">0006-2960</issn><issn pub-type="epub">1520-4995</issn><publisher><publisher-name>American
Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26368022</article-id><article-id pub-id-type="pmc">4613865</article-id><article-id pub-id-type="doi">10.1021/acs.biochem.5b00789</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Structure and Mechanism of a Viral Collagen Prolyl
Hydroxylase</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Longbotham</surname><given-names>James
E.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Levy</surname><given-names>Colin</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Johannissen</surname><given-names>Linus O.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Tarhonskaya</surname><given-names>Hanna</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Jiang</surname><given-names>Shuo</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Loenarz</surname><given-names>Christoph</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Flashman</surname><given-names>Emily</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Hay</surname><given-names>Sam</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Schofield</surname><given-names>Christopher J.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath10"><name><surname>Scrutton</surname><given-names>Nigel S.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Centre
for Synthetic Biology of Fine and Specialty Chemicals (SYNBIOCHEM),
Manchester Institute of Biotechnology, <institution>The
University of Manchester</institution>, Manchester M1 7DN, <country>United Kingdom</country></aff><aff id="aff2"><label>&#x02021;</label>Chemistry
Research Laboratory, <institution>University of Oxford</institution>, 12 Mansfield Road, Oxford OX1 3TA, <country>United Kingdom</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>nigel.scrutton@manchester.ac.uk</email>. Phone: <phone>+44(0)161 306 5152</phone>.</corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>09</month><year>2015</year></pub-date><pub-date pub-type="ppub"><day>06</day><month>10</month><year>2015</year></pub-date><volume>54</volume><issue>39</issue><fpage>6093</fpage><lpage>6105</lpage><history><date date-type="received"><day>15</day><month>07</month><year>2015</year></date><date date-type="rev-recd"><day>11</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 American Chemical Society</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Attribution (CC-BY) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html">License</ext-link>, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0009" id="ab-tgr1"/></p><p>The
Fe(II)- and 2-oxoglutarate (2-OG)-dependent dioxygenases comprise
a large and diverse enzyme superfamily the members of which have multiple
physiological roles. Despite this diversity, these enzymes share a
common chemical mechanism and a core structural fold, a double-stranded
&#x003b2;-helix (DSBH), as well as conserved active site residues. The
prolyl hydroxylases are members of this large superfamily. Prolyl
hydroxylases are involved in collagen biosynthesis and oxygen sensing
in mammalian cells. Structural&#x02013;mechanistic studies with prolyl
hydroxylases have broader implications for understanding mechanisms
in the Fe(II)- and 2-OG-dependent dioxygenase superfamily. Here, we
describe crystal structures of an N-terminally truncated viral collagen
prolyl hydroxylase (vCPH). The crystal structure shows that vCPH contains
the conserved DSBH motif and iron binding active site residues of
2-OG oxygenases. Molecular dynamics simulations are used to delineate
structural changes in vCPH upon binding its substrate. Kinetic investigations
are used to report on reaction cycle intermediates and compare them
to the closest homologues of vCPH. The study highlights the utility
of vCPH as a model enzyme for broader mechanistic analysis of Fe(II)-
and 2-OG-dependent dioxygenases, including those of biomedical interest.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>bi5b00789</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>bi-2015-007898</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">Prolyl hydroxylases are members
of the large and diverse superfamily of enzymes, the Fe(II)- and 2-oxoglutarate
(2-OG)-dependent dioxygenases.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Enzymes
from the 2-OG oxygenase superfamily catalyze a large and diverse range
of reactions and have a variety of physiological roles.<sup><xref ref-type="bibr" rid="ref2">2</xref>&#x02212;<xref ref-type="bibr" rid="ref4">4</xref></sup> Examples include antibiotic synthesis in microorganisms,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> histone modifications,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and DNA repair/RNA modification.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup> Despite this
diversity of roles, these enzymes share a common reaction mechanism
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> They utilize Fe(II) and the cosubstrate 2-OG
in the active site to activate oxygen, resulting in the two-electron
oxidation of the substrate. This is coupled to the decarboxylation
of 2-OG to produce carbon dioxide and succinate (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). This oxidative decarboxylation
of 2-OG yields a highly reactive Fe(IV) intermediate, which is responsible
for abstraction of hydrogen from the substrate.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> As
well as a conserved reaction mechanism, these enzymes have a highly
conserved double-stranded &#x003b2;-helix (DSBH) domain that supports
a highly conserved HXD/E&#x000b7;&#x000b7;&#x000b7;H iron binding motif.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> The selectivity of individual enzymes is dictated by additional
motifs that surround the DSBH core.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Mechanism of the Fe(II)- and 2-OG-dependent
dioxygenases. In its
resting position, the enzyme active site contains a ferrous iron ion
coordinated by two His residues and one Asp residue (step I). The
binding of 2-OG displaces two water molecules (step II); binding of
a third water molecule is displaced/weakened upon substrate binding
(step III). Substrate binding allows oxygen binding, which subsequently
forms an anionic intermediate (step IV) that attacks the ketone of
2-OG to form a cyclic peroxide molecule (step V). The collapse of
this intermediate causes formation of the Fe(IV)oxo species, which
abstracts a hydrogen from the substrate (step VI). The substrate radical
then reacts with the Fe(III)&#x02013;OH complex to form the hydroxylated
substrate (step VII) and restores the enzyme to the resting position.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0002" id="gr1" position="float"/></fig><p>Prolyl hydroxylases catalyze the
hydroxylation of proline residues
in proteins and peptides. This post-translational modification is
important in cellular oxygen sensing, collagen biosynthesis, and ribosomal
protein synthesis by the action of prolyl hydroxylase domain proteins
(PHDs), collagen prolyl hydroxylases, and the ribosomal prolyl-3-hydroxylase
OGFOD1,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> respectively. In humans, there
are three PHD enzymes (PHD1&#x02013;3) that modulate the stability
of isoforms of the hypoxia inducible factor (HIF), a transcription
factor responsible for regulation of genes involved in the hypoxic
response.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Of the three PHD enzymes, PHD2 is the most
important in oxygen sensing,<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> and studies of PHD2
have characterized its unusually slow reaction with oxygen, relative
to other Fe(II)- and 2-OG-dependent dioxygenases, which is thought
to be important in its role as an oxygen sensor.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup></p><p>The mammalian tetrameric collagen prolyl-4-hydroxylases
(C-P4H)
target X-Pro-Gly repeats in procollagen polypeptides, leading to the
increased stability of the collagen triple helix.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Hydroxylation of collagen-like domains and proline-rich
proteins also occurs in plants and algae, and various prolyl hydroxylases
have been identified. These enzymes are generally smaller and monomeric
compared to the mammalian collagen prolyl hydroxylases. They also
differ in terms of substrate specificity and can hydroxylate different
sequences of proline-rich peptides.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Many
of the plant prolyl hydroxylases are thought to be involved in the
production of hydroxyproline-rich glycoproteins (HRGPs), major components
of plant cell walls as well as other cellular functions.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup></p><p>A viral collagen prolyl hydroxylase from <italic>Paramecium bursaria</italic> Chlorella Virus-1 (PBCV-1) was first
described by Eriksson and co-workers.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The enzyme has a distinct sequence similarity
(between 15 and 23% identity) with the C-terminal half of the &#x003b1;-subunit
of animal collagen prolyl hydroxylases. Substrates for the enzyme
were determined after sequence analysis of the <italic>PBCV-1</italic> genome highlighted many open reading frames for proteins containing
regions of proline-rich repeats, similar to the collagen prolyl hydroxylase
substrates.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Hoffart et al. have shown
that during the reaction cycle a high-spin Fe(IV) intermediate forms,
which is responsible for the abstraction of hydrogen from substrate
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> High-spin Fe(IV) intermediates are often transient
in nature and therefore difficult to characterize. That this intermediate
can be observed makes mechanistic analysis of the enzymatic reaction
cycle accessible. The enzyme is relatively small for a 2-OG oxygenase
(25 kDa) and is a monomeric protein. It is soluble at high concentrations
and can be tagged with a polyhistidine (His<sub>6</sub>) extension.
This facilitates rapid purification in quantities suitable for (time-resolved)
spectroscopy studies for which a relatively high concentration of
protein is required.</p><p>Here, crystal structures of the viral collagen
prolyl hydroxylase
from <italic>P. bursaria</italic> Chlorella Virus-1 (PBCV-1) in both
manganese-bound and zinc- and 2-OG-bound conformations are reported.
Crystallographic determination of co-complexes with a peptide substrate
was not possible despite considerable effort, so molecular dynamics
simulations were used to simulate the mode of binding of a proline-rich
peptide substrate. Stopped-flow spectroscopy was used to monitor the
formation and/or decay of a metal&#x02013;ligand charge-transfer (MLCT)
complex and formation of a hydroxylated product, providing information
about the kinetics of the reaction cycle and information about the
spectroscopic properties of chemical reaction intermediates (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><sec id="sec2"><title>Experimental
Procedures</title><sec id="sec2.1"><title>Protein Expression and Purification</title><p>A gene encoding
an N-terminally truncated variant of prolyl hydroxylase from <italic>P. bursaria</italic> Chlorella Virus-1 (PBCV-1) (residues 36&#x02013;242)
(NCBI GI number 9631654) was synthesized with codon optimization for <italic>Escherichia coli</italic> and cloned into pET-28a with an N-terminal
His<sub>6</sub> tag using the NdeI/XhoI sites. The variant was produced
to remove a predicted N-terminal transmembrane helix. The truncated
protein (hereafter termed vCPH) was produced in <italic>E. coli</italic> Rosetta 2(DE3)pLysS cells (Novagen) and purified using a three-step
process. The initial nickel affinity chromatography step used a 5
mL HisTrap HP (GE Healthcare) column with a protocol involving a wash
step in 0.5 M NaCl, 20 mM sodium phosphate buffer, and 20 mM imidazole
(pH 7.4) followed by an elution gradient from 50 to 250 mM imidazole.
After elution, vCPH was exhaustively dialyzed in 20 mM Tris (pH 8)
before being loaded onto a ResourceQ (GE Healthcare) anionic exchange
column. An elution gradient was applied to the column with the NaCl
concentration increasing from 0 to 375 mM over 20 column volumes.
After elution, vCPH was concentrated and diluted into 0.2 M EDTA and
12 mM ammonium acetate to remove metal impurities and left overnight
at 4 &#x000b0;C. vCPH was then further concentrated before being loaded
onto a HiLoad 26/600 Superdex 200 (GE Healthcare) gel filtration column,
equilibrated with 100 mM HEPES (pH 7.5).</p></sec><sec id="sec2.2"><title>Peptide Synthesis</title><p>Peptides were synthesized as C-terminal
amides as described previously<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> using
a CS Bio CS336 multichannel solid phase peptide synthesizer with Fmoc-protected
amino acids, PL-AMS resin (Polymer Laboratories) with Rink amide linker
and DIC/HOBT coupling, deprotected (88:5:5:2 CF<sub>3</sub>CO<sub>2</sub>H:phenol:H<sub>2</sub>O:triisopropylsilane),
and purified by reversed phase high-performance liquid chromatography
using a Vydac 218TP C18 10-15u column (Grace Davison Discovery Sciences).
Fmoc-<italic>trans</italic>-4-hydroxyproline (Fmoc-Hyp) was from Bachem
UK.</p></sec><sec id="sec2.3"><title>Substrate Hydroxylation Assay</title><p>Hydroxylase activity
was measured by mass spectrometry. Reactions were performed in a total
volume of 50 &#x003bc;L containing 50 mM Tris-HCl buffer (pH 7.5), with
4 mM ascorbate, 300 mM 2-OG, a 50 &#x003bc;M Fe(NH<sub>4</sub>)<sub>2</sub>(SO<sub>4</sub>)<sub>2</sub>&#x000b7;6H<sub>2</sub>O stock solution
(prepared freshly in 200 &#x003bc;M HCl to prevent oxidation), 4 &#x003bc;M
enzyme, and 100 &#x003bc;M substrate. Controls used buffer instead of
enzyme; all assay tubes were shaken in an incubator at 37 &#x000b0;C
for the appropriate amount of time and then quenched with an equal
volume of methanol (50 &#x003bc;L).</p><p>Mass spectrometry measurements
were performed after spotting 2 &#x003bc;L of a sample mixture {50%
peptide solution and 50% CHCA matrix [recrystallized &#x003b1;-cyano-4-hydroxy-cinnamic
acid (Laser Bio Laboratories)]} onto a MALDI 96-well sample plate.
Peptide hydroxylation was measured in positive ion mode, with a laser
voltage of 12000 and a reflectron voltage of 5200. Spectra were analyzed
using MassLynx version 4.0, and the percentage peptide hydroxylation
was calculated using <xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>:<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_m001" position="anchor"/><label>1</label></disp-formula>where <italic>I</italic><sub>OH</sub> and <italic>I</italic><sub>non-OH</sub> correspond to peak intensities
of hydroxylated and nonhydroxylated peptides, respectively.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p></sec><sec id="sec2.4"><title>Crystallization</title><p>vCPH was concentrated
to 30 mg/mL in
100 mM HEPES (pH 7.5) before being supplemented with 1.1 mM MnCl<sub>2</sub>. Crystals of vCPH were grown by sitting drop vapor diffusion
and incubated at 4 &#x000b0;C and arose from a reservoir solution containing
0.1 M imidazole, a MES monohydrate (acid) buffer system, 0.1 M amino
acids [0.2 M sodium <sc>l</sc>-glutamate, 0.2 M alanine (racemic),
0.2 M glycine, 0.2 M lysine HCl (racemic), and 0.2 M serine (racemic)],
and 30% PEGMME 550 PEG 20K (pH 6.5) [Morpheus HT96 condition H1, Molecular
Dimensions]. The complexed 2-OG structure was obtained by soaking
crystals in mother liquor supplemented with 250 mM ZnSO<sub>4</sub> and 100 mM 2-OG for 16 h. All crystals were subsequently cryofrozen
by being plunged into liquid nitrogen.</p></sec><sec id="sec2.5"><title>Data Collection and Phase
Determination</title><p>X-ray diffraction
data were collected from single cryocooled crystals at Diamond Light
Source and subsequently integrated and scaled using XDS.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup></p></sec><sec id="sec2.6"><title>Model Building and Refinement</title><p>All
structures were determined
by molecular replacement in Phaser<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> using
a search model derived from a related prolyl hydroxylase from <italic>Chlamydomonas reinhardtii</italic> [Cr-P4H; Protein Data Bank (PDB)
entry 2JIG].
Xtriage<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> was used to analyze the data
sets and indicated significant twinning was present in both the Mn(II)
and 2-OG data. Twinning was detected using Britton analyses, an H-test,
and the maximum likelihood methodology as implemented in Xtriage.
A pseudomerohedral twin operator (<italic>h</italic>, &#x02212;<italic>k</italic>, &#x02212;<italic>l</italic>) was found and used to automatically
account for the twinning during subsequent refinement. The resulting
models were completed through iterative rounds of rebuilding in COOT<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and refinement in Phenix.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Structure validation with MOLPROBITY<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> and PDB_REDO<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> was integrated
as part of the iterative rebuild and refinement procedure.</p></sec><sec id="sec2.7"><title>Molecular
Modeling of a Peptide-Bound Structure</title><p>In
the absence of a peptide-bound crystal structure, a model was generated
by first superimposing the structure of the 2-OG-bound vCPH with that
of Cr-P4H in complex with a peptide (PDB entry 3GZE) using Secondary
Structure Matching (SSM) in Coot.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> The
peptide substrate from superimposed model 3GZE was then substituted for the sequence
of the peptide substrate of vCPH, PKPAPK, and merged into the PDB
file of the vCPH 2-OG structure (vCPH-2OG-Pep). The resultant model
was subsequently superimposed onto the vCPH&#x000b7;Mn(II) structure
and the peptide backbone real space refined into the electron density
observed in this structure from a symmetry-related monomer&#x02019;s
N-terminal His tail that was ordered within the peptide binding site
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). The side
chain orientations were used to inform initial rotamer choices of
the mutated peptide; however, these were not constrained in the molecular
dynamics (MD) simulations. The resulting model was then exported to
the Rosetta FlexPepDock web server<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> and
used as the starting model for molecular dynamics and energy minimization.
The peptide altered its position to a conformation similar to that
of the peptide bound in the 3GZE structure of Cr-P4H. MD simulations were used to explore
the conformation of the &#x003b2;II&#x02212;&#x003b2;III loop in the absence
and presence of the peptide substrate (with 2-OG and Mn bound in both
cases). In the Mn(II)-bound structure, the &#x003b2;II&#x02212;&#x003b2;III
loop adopts a folded back conformation, similar to that of Cr-P4H
in the absence of ligand.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> The &#x003b1;1&#x02212;&#x003b2;2
loop was first modeled using SWISS-MODEL,<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> and MD simulations were then conducted using Gromacs<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> version 4.6.1 with the Gromos 53a6 force field.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> To ensure maximal sampling, an initial 10 ns of simulation
at 300 K was followed by periodic annealing with the temperature alternating
between 300 and 350 K every 1 ns, with heating and cooling over a
10 ps window for a total of 50 ns. This method did not require constraints
on the protein or peptide to avoid unfolding during the high-temperature
dynamics, but for the peptide-bound protein, a center-of-mass distance
restraint of 10 kJ mol<sup>&#x02013;1</sup> &#x000c5;<sup>&#x02013;2</sup> was applied between the peptide and the protein to prevent unbinding.</p></sec><sec id="sec2.8"><title>Dissociation Constant Determination</title><p>The dissociation
constant (<italic>K</italic><sub>d</sub>) of the 2-OG&#x02013;vCPH
complex was determined by measuring absorbance changes associated
with the MLCT complex after titration of 2-OG into a solution of vCPH&#x000b7;Fe(II)
using a Cary 50Bio UV&#x02013;vis spectrophotometer (Agilent technologies).
After addition of a small volume of a 2-OG solution, spectra were
normalized to account for the addition of small volumes of ligand
and the absorbance was set to zero at 700 nm. The absorbance values
at 520 nm were plotted against ligand concentration, and the data
were then fitted to determine the <italic>K</italic><sub>d</sub> for
the enzyme&#x02013;2-OG complex (<xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>):<disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_m002" position="anchor"/><label>2</label></disp-formula>where <italic>Y</italic> is the relative change
in fluorescence, <italic>Y</italic><sub>0</sub> is fluorescence in
the absence of ligand, d<italic>Y</italic> is the change in <italic>Y</italic>, [E] is the enzyme concentration, [L] is the ligand concentration,
and <italic>K</italic><sub>d</sub> is the vCPH&#x02013;2-OG complex
dissociation constant.</p><p>The dissociation constants for peptide&#x02013;vCPH
complexes were determined by tryptophan fluorescence quenching using
a Cary Eclipse fluorescence spectrophotometer (Agilent technologies).
The crystal structure shows Trp237 present in the peptide and 2-OG
binding site, indicating binding of ligands would affect tryptophan
fluorescence. For tryptophan fluorescence experiments, samples were
excited at 295 nm and the integrals of the area under the emission
spectra (peak at &#x02248;350 nm) were first measured and adjusted
to account for volume changes upon the addition of peptide. The initial
fluorescence intensity was adjusted to 1, and fluorescence intensities
with ligand bound were calculated relative to the initial fluorescence
and described as a factor of 1. The relative fluorescence was then
plotted against ligand concentration and fitted to <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref> to calculate the dissociation constant.</p></sec><sec id="sec2.9"><title>Transient State Kinetics</title><p>Transient state kinetic studies
of the reaction cycle were investigated using a stopped-flow spectrophotometer
(TgK Scientific). The stopped-flow equipment used a 75 W xenon Arc
lamp and a photomultiplier tube as the absorbance and fluorescence
detectors. Prior to measurement of absorbance changes, a baseline
for protein absorbance of protein and buffer was taken. For fluorescence
measurements, the initial fluorescence intensity was set to 100%,
and subsequent fluorescence measurements were relative to this intensity.
Changes in fluorescence emission were measured as a percentage of
signal change.</p><p>Single-wavelength stopped-flow data were analyzed
using OriginPro software (version 8.5) to give an observed rate constant
for the reaction. The data were fitted to an exponential decay function:<disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_m003" position="anchor"/><label>3</label></disp-formula>where <italic>A</italic>*<sub><italic>i</italic></sub> is the amplitude, <italic>t</italic> is the time, <italic>k</italic><sub><italic>i</italic></sub> is the observed rate constant
of the <italic>i</italic>th exponential component, <italic>y</italic> is the change in absorbance or fluorescence, and <italic>b</italic> is the offset value to take into account the non-zero baseline.
Transients were fitted from the dead time of the instrument (approximately
2 ms), and each transient was independently fitted to the moving average
(nine consecutive points were averaged) of the change in absorbance
or fluorescence. Typically, three to five transients were averaged
to give the data shown.</p><p>The dependence of the observed rate
constants on the concentration
of ligand was used to gain more information about the spectral features
being measured. When the <italic>k</italic><sub>obs</sub> was plotted
against ligand/substrate concentration and showed a linear relationship,
the data were fitted to the following equation for second-order kinetics:<disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_m004" position="anchor"/><label>4</label></disp-formula>where <italic>k</italic><sub>obs</sub> is
the observed rate constant, <italic>k</italic><sub>on</sub> is the
on-rate constant, [L] is the ligand or substrate concentration, and <italic>k</italic><sub>off</sub> is the off-rate constant.</p></sec><sec id="sec2.10"><title>Rapid Quench
Mass Spectrometry Experiments</title><p>Rapid quench-flow
experiments were used to measure levels of cosubstrate and product
on a millisecond time scale during a reaction. A rapid quench-flow
apparatus (RQF-63, TgK Scientific) was used in an anaerobic glovebox
(Belle Technologies). Samples were quenched after the reaction solution
had been mixed with 1% CF<sub>3</sub>CO<sub>2</sub>H (TFA) and analyzed
using MALDI-TOF-MS (peptide hydroxylation) or LC&#x02013;MS (succinate
formation).<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref18">18</xref></sup> For LC&#x02013;MS, chromatographic
separation was performed at 50 &#x000b0;C using a Waters ACQUITY BEH
Amide 1.7 &#x003bc;m, 2.1 mm &#x000d7; 100 mm column on a Waters ACQUITYTM
ultraperformance liquid chromatography (UPLC) system. The following
eluents were used: mobile phase A, 10% H<sub>2</sub>O, 90% (v/v) acetonitrile,
and 10 mM ammonium formate; mobile phase B, 50% H<sub>2</sub>O, 50%
(v/v) acetonitrile, and 10 mM ammonium formate. The elution gradient
was 0 to 5.0 min linear from 10 to 50% B and 5.0 to 7.0 min at 10%
B for re-equilibration of the column. A constant flow rate of 0.4
mL/min was used. Analytes were detected in negative ionization mode
using single-reaction monitoring (SRM) on a Quattro triple-quadruple
mass spectrometer (Waters) with a cone voltage of 15 V and a capillary
voltage of 3.0 kV. The desolvation temperature was set to 250 &#x000b0;C
and the source temperature to 120 &#x000b0;C. For MALDI-MS, peptide hydroxylation
was measured as described above.</p></sec></sec><sec id="sec3"><title>Results</title><sec id="sec3.1"><title>Description
of Mn(II)-Bound vCPH and vCPH in Complex with 2-OG</title><p>Two structures
of vCPH were obtained, one in complex with Mn(II)
and another in complex with Zn(II) and a 2-OG molecule (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Mn(II) and Zn(II) were used
in crystal screens, rather than Fe(II), to make an inactive enzyme
complex. The Mn(II)-bound structure contains two molecules per asymmetric
unit, and these superimpose with a root-mean-square deviation (rmsd)
of 0.34 &#x000c5;. Several electron density features remain within the
active site of the Mn(II)-complexed structure; these proved to be
insufficient to accurately model and have been highlighted as UNK
in the final structure. The metal ions were modeled on the basis of
the known metals present during protein production and crystallogenesis
and validated using the CheckMyMetal (CMM) server.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> The crystal packing of the vCPH&#x000b7;Mn(II) structure shows
a symmetry-related molecule from a neighboring monomer within the
crystal lattice has inserted a portion of its N-terminus and His tag
linker into the peptide binding site of each monomer.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Data Collection and Refinement Statistics
of the Mn- and 2-OG-Bound Structures of vCPH</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">Mn-bound vCPH</th><th style="border:none;" align="center">2-OG-bound vCPH</th></tr></thead><tbody><tr><td style="border:none;" align="left">wavelength (&#x000c5;)</td><td style="border:none;" align="left">1.0</td><td style="border:none;" align="left">1.0</td></tr><tr><td style="border:none;" align="left">resolution range (&#x000c5;)</td><td style="border:none;" align="left">28.42&#x02013;1.7 (1.761&#x02013;1.7)</td><td style="border:none;" align="left">28.43&#x02013;1.598 (1.655&#x02013;1.598)</td></tr><tr><td style="border:none;" align="left">space
group</td><td style="border:none;" align="left"><italic>P</italic>1211</td><td style="border:none;" align="left"><italic>P</italic>1211</td></tr><tr><td style="border:none;" align="left">unit cell dimensions</td><td style="border:none;" align="left">33.77 &#x000c5;, 157.67 &#x000c5;, 41.01 &#x000c5;, 90&#x000b0;, 90.02&#x000b0;,
90&#x000b0;</td><td style="border:none;" align="left">33.79 &#x000c5;, 156.95 &#x000c5;, 41.24 &#x000c5;,
90&#x000b0;, 90.02&#x000b0;,
90&#x000b0;</td></tr><tr><td style="border:none;" align="left">total no. of reflections</td><td style="border:none;" align="left">137720&#x000a0;(8139)</td><td style="border:none;" align="left">187145&#x000a0;(17646)</td></tr><tr><td style="border:none;" align="left">no. of unique reflections</td><td style="border:none;" align="left">44328&#x000a0;(3627)</td><td style="border:none;" align="left">55206&#x000a0;(5361)</td></tr><tr><td style="border:none;" align="left">multiplicity</td><td style="border:none;" align="left">3.1&#x000a0;(2.2)</td><td style="border:none;" align="left">3.4&#x000a0;(3.3)</td></tr><tr><td style="border:none;" align="left">completeness (%)</td><td style="border:none;" align="left">94.56&#x000a0;(77.65)</td><td style="border:none;" align="left">97.68&#x000a0;(94.94)</td></tr><tr><td style="border:none;" align="left">mean <italic>I</italic>/&#x003c3;(<italic>I</italic>)</td><td style="border:none;" align="left">10.40&#x000a0;(1.92)</td><td style="border:none;" align="left">13.55&#x000a0;(2.38)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>merge</sub></td><td style="border:none;" align="left">0.080&#x000a0;(0.405)</td><td style="border:none;" align="left">0.0576&#x000a0;(0.416)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>meas</sub></td><td style="border:none;" align="left">0.096</td><td style="border:none;" align="left">0.069</td></tr><tr><td style="border:none;" align="left">CC<sub>1/2</sub></td><td style="border:none;" align="left">0.996&#x000a0;(0.715)</td><td style="border:none;" align="left">0.998&#x000a0;(0.781)</td></tr><tr><td style="border:none;" align="left">CC*</td><td style="border:none;" align="left">0.999&#x000a0;(0.913)</td><td style="border:none;" align="left">0.999&#x000a0;(0.937)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>work</sub></td><td style="border:none;" align="left">0.156</td><td style="border:none;" align="left">0.178</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>free</sub></td><td style="border:none;" align="left">0.202</td><td style="border:none;" align="left">0.211</td></tr><tr><td style="border:none;" align="left">no. of non-hydrogen atoms</td><td style="border:none;" align="left">3577</td><td style="border:none;" align="left">3326</td></tr><tr><td style="border:none;" align="left">no. of macromolecules</td><td style="border:none;" align="left">3045</td><td style="border:none;" align="left">2907</td></tr><tr><td style="border:none;" align="left">no. of ligands</td><td style="border:none;" align="left">6</td><td style="border:none;" align="left">23</td></tr><tr><td style="border:none;" align="left">no. of waters</td><td style="border:none;" align="left">767</td><td style="border:none;" align="left">551</td></tr><tr><td style="border:none;" align="left">no. of protein
residues</td><td style="border:none;" align="left">378</td><td style="border:none;" align="left">360</td></tr><tr><td style="border:none;" align="left">rmsd for bonds (&#x000c5;)</td><td style="border:none;" align="left">0.005</td><td style="border:none;" align="left">0.014</td></tr><tr><td style="border:none;" align="left">rmsd for angles (deg)</td><td style="border:none;" align="left">0.88</td><td style="border:none;" align="left">1.46</td></tr><tr><td style="border:none;" align="left">Ramachandran favored (%)</td><td style="border:none;" align="left">98</td><td style="border:none;" align="left">98</td></tr><tr><td style="border:none;" align="left">Ramachandran outliers
(%)</td><td style="border:none;" align="left">0</td><td style="border:none;" align="left">0.57</td></tr><tr><td style="border:none;" align="left">Clash
score</td><td style="border:none;" align="left">1.49</td><td style="border:none;" align="left">2.92</td></tr><tr><td style="border:none;" align="left">average <italic>B</italic> factor (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">15.69</td><td style="border:none;" align="left">21.52</td></tr><tr><td style="border:none;" align="left">average <italic>B</italic> factor for macromolecules (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">12.29</td><td style="border:none;" align="left">19.96</td></tr><tr><td style="border:none;" align="left">average <italic>B</italic> factor for ligands (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">22.67</td><td style="border:none;" align="left">16.08</td></tr><tr><td style="border:none;" align="left">average <italic>B</italic> factor for solvent (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">35.30</td><td style="border:none;" align="left">33.28</td></tr></tbody></table></table-wrap><p>The vCPH&#x000b7;Mn(II) structure is comprised of a total
of 185 of
a possible 206 residues spanning residues 34&#x02013;78 and 100&#x02013;242
(numbering is maintained from the full length gene; residues 34 and
35 are the start of the His tag linker) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). The C-terminal Lys242 is disordered in
chain A. The monomeric fold is comprised of two &#x003b2;-sheets and
two &#x003b1;-helices (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Starting at the N-terminus, the &#x003b2;1 strand extends
the major sheet of the DSBH (&#x003b2;I, VIII, III, and VI) by hydrogen
bonding to &#x003b2;VI. This is followed by &#x003b1;1, which packs across
the major &#x003b2;-sheet, and a disordered loop region, 21 residues
long. After this, &#x003b2;2 extends the major &#x003b2;-sheet by hydrogen
bonding to &#x003b2;I, followed by &#x003b1;2, which packs across the
entire major &#x003b2;-sheet (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). The region following the &#x003b2;I strand (Tyr148&#x02013;Asp157)
is present as a &#x003b2;-strand in other members of this enzyme family.
However, in the Mn-bound vCPH structure, this region does not appear
to maintain regular hydrogen bonding associated with &#x003b2;-sheets.
Despite this, this region is still labeled &#x003b2;II to conserve the
nomenclature of this highly conserved structural motif. The &#x003b2;VII
strand also appears not to form uniform antiparallel &#x003b2;-sheet
hydrogen bonds with the adjacent &#x003b2;IV strand. Two pairs of cysteine
residues form disulfide bonds in vCPH. One pair, Cys47 and Cys129,
links a region N-terminal to &#x003b2;1 to the loop between &#x003b1;2
and &#x003b2;I (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). It is possible that this linkage may stabilize the &#x003b1;2&#x02212;&#x003b2;I
loop and allow the &#x003b1;2 helix to pack along the major &#x003b2;-sheet.
The second pair consists of Cys158 and Cys162, which are part of a
&#x003b2;II&#x02212;&#x003b2;III loop region near the active site.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Structure of
a viral collagen prolyl hydroxylase (vCPH). (A) Overall
topology of the Mn-bound vCPH (PDB entry 5C5U). &#x003b2;-Strands (labeled I&#x02013;VIII)
of the DSBH motif are colored red, additional &#x003b2;-strands gray,
and &#x003b1;-helices and loop regions blue. The Mn(II) ion is shown
as a dark green sphere. A peptide found in a neighboring molecule
in the crystal lattice is colored green. A disordered loop region
is shown as a dashed line. (B) Changes in the &#x003b2;II loop upon
binding of 2-OG to vCPH. Residues from the Mn-bound structure are
colored red, and residues from the 2-OG-bound structure (PDB entry 5C5T) are colored cyan.
The metal binding residues are colored yellow; the Zn(II) ion is shown
as a magenta sphere, and the 2-OG molecule is colored green. The inset
shows the interactions of Tyr149 with residues in the 2-OG-bound structure.
(C) Position of 2-OG in the active site of vCPH. Residues from the
Mn-bound structure are colored red. Residues from the 2-OG-bound structure
are colored cyan, and hydrogen bonds are shown as dashed lines. The
Zn(II) ion is shown as a magenta sphere, and waters are shown as blue
spheres (Mn-bound structure only). 2-OG is colored green along with
the 2<italic>F</italic><sub>o</sub> &#x02013; <italic>F</italic><sub>c</sub> density, contoured at the 2&#x003c3; level. Tyr149 from the
2-OG-bound structure has been omitted for the sake of clarity.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0003" id="gr2" position="float"/></fig><p>The overall topology of the 2-OG-bound
structure is similar to
that of the Mn-bound structure. However, significant changes in the
&#x003b2;II strand active site residues are observed upon 2-OG binding
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B) (&#x003b2;II
supports two of the three metal binding residues). In the Mn-bound
structure, Tyr149 is flipped out away from the active site, but when
2-OG binds to vCPH, Tyr149 is flipped into the active site such that
it is positioned to hydrogen bond to a water molecule that hydrogen
bonds to the C-1 carboxylate moiety of 2-OG. Tyr148 and Tyr150 also
appear in a different orientation in the 2-OG-bound structure compared
to that in the Mn-bound structure. These changes allow the &#x003b2;II
and &#x003b2;VII strands to form regular hydrogen bonds to their adjacent
&#x003b2;-strands. They also mean certain residues are more ordered
in the 2-OG-bound structure as 16 residues of the &#x003b1;1&#x02212;&#x003b2;2
loop region are disordered (Lys78&#x02013;Asp93) in the 2-OG-bound
structure, compared to the 21 residues (Ser79&#x02013;Ser99) in the
Mn-bound structure. The change in orientation of the Tyr149 side chain
allows interactions with both His152 and Arg97 (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B, inset); Arg97 in the Mn(II) structure,
however, forms part of the disordered region.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Model of peptide-bound
vCPH. (A) Electron density of a symmetry-related
monomer&#x02019;s N-terminal His tail that was ordered within the peptide
binding site of the Mn(II)-bound structure. The green map shows the <italic>F</italic><sub>o</sub> &#x02013; <italic>F</italic><sub>c</sub> omit
map contoured at 2&#x003c3;. The blue map shows the 2<italic>F</italic><sub>o</sub> &#x02013; <italic>F</italic><sub>c</sub> final refinement
map contoured at 1&#x003c3;. Residues shown as balls and sticks are
residues 34&#x02013;40 of chain A. The red ribbon is the backbone of
chain A. The gray surface rendering is the adjacent chain A from within
the crystallographic lattice highlighting the clear interaction of
this region of chain. (B) Location of the peptide substrate PKPAPK
modeled into the structure of vCPH. vCPH is colored gray; the Zn(II)
ion is shown as a magenta sphere, and the 2-OG molecule is colored
green. The peptide is shown as yellow sticks surrounded by cyan spheres.
Residues of the peptide substrate are labeled in yellow, and residues
from the crystal structure are labeled in black. Hydrogen bonds are
shown as black dashed lines. (C) Conformation of the &#x003b2;II&#x02212;&#x003b2;III
loop with and without a peptide bound. Peptide-free protein (cyan)
and peptide-bound protein (orange, with peptide colored yellow). The
traces follow the center of mass of the &#x003b1;-carbons of residues
125&#x02013;128 during 50 ns of periodic annealing initiated after
10 ns of 300 K simulation, with the circle indicating the starting
position. (D and E) rmsd of the &#x003b2;II&#x02212;&#x003b2;III loop relative
to the average following alignment to the protein backbone. For comparison,
the rmsd for the periodic annealing simulations (cyan for peptide-free,
orange for peptide-bound) is shown as well as that for 300 K simulations
(gray).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0004" id="gr3" position="float"/></fig><p>The metals bound in the active
sites of our structures are bound
by the conserved iron-coordinating residues His152, Asp154, and His221.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> The proximal His152 and Asp154 residues originate
from the &#x003b2;II strand, and the distal His221 originates from the
&#x003b2;VII strand (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Three water molecules are also coordinated to the Mn(II)
ion and occupy places <italic>trans</italic> to both the equatorial
and axial histidines (His152 and His221, respectively) and <italic>trans</italic> to Asp154 (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C). In the 2-OG-bound structure, the 2-OG molecule
is bound to the Zn(II) ion in a bidentate manner where one oxygen
of the C-1 carboxylate is ligated <italic>trans</italic> to the axial
His221 and the C-2 carbonyl is <italic>trans</italic> to Asp154. The
position <italic>trans</italic> to His152, which contained a water
molecule in the Mn-bound structure, is now vacant when 2-OG is bound.
It is likely that this position is the site of oxygen binding according
to the consensus mechanism (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). This would mean that the active site might be required
to undergo a rearrangement to position the reactive oxygen adjacent
to the oxidized bond of the substrate, as observed for other prolyl
hydroxylases.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Several hydrogen bonds,
electrostatic contacts, and hydrophobic interactions are made with
the 2-OG molecule within the 2-OG binding pocket. These include the
conserved basic Lys231 residue (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C).</p></sec><sec id="sec3.2"><title>Peptide Substrate Interactions with vCPH</title><p>In the absence
of a peptide-bound crystal structure, a model of vCPH was generated
with peptide PKPAPK bound in the active site (see <xref rid="sec2" ref-type="other">Experimental Procedures</xref>). This is a shorter sequence of (PAPK)<sub><italic>n</italic></sub>, a substrate described by Hoffart et al.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> This was used as the starting model for molecular
dynamics and energy minimization studies (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). PKPAPK adopts
a PPII helical structure in the model and binds vCPH across the entrance
to the active site between the &#x003b2;II&#x02212;&#x003b2;III loop and
the loop region between &#x003b1;1 and &#x003b2;2 (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). This is a conformation similar to that
of the peptide bound in the structure of Cr-P4H.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> The peptide predominantly interacts with vCPH via hydrophobic
residues from the &#x003b2;2 and &#x003b2;II strands (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Hydrogen bonds are formed
from Tyr149 to the main chain atoms of Pro1, and Arg167 forms hydrogen
bonds to the main chain atoms of Ala4 and Pro3. Pro3 of the peptide
is pointed toward the Zn(II) ion in the active site, placing the C4
atom in the proximity of the metal ion, indicating that the peptide
is positioned optimally for hydroxylation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B).</p><p>The conformations of the two loops
near the peptide binding site were simulated using MD calculations
after the disordered &#x003b1;1&#x02212;&#x003b2;2 loop was modeled using
SWISS-MODEL. The simulations showed that in the absence of peptide
the &#x003b2;II&#x02212;&#x003b2;III loop adopted a more open conformation
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C), whereas
with peptide bound, this loop quickly adopts a conformation closed
around the peptide. The fact that the loop in the peptide-bound protein
remains in this closed conformation during the periodic annealing
reveals that this is a metastable state. On the other hand, as can
be seen from the rmsd (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>D,E) and the traces following the loop motion (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C), the &#x003b2;II&#x02212;&#x003b2;III
loop is likely to be more disordered without the peptide bound.</p></sec><sec id="sec3.3"><title>Rapid Quench-Flow Experiments Observing Product Formation</title><p>The PBCV-1 genome contains many predicted proteins with proline-rich
repeat sequences, including proteins with (PAPK)<sub><italic>n</italic></sub> repeats in which <italic>n</italic> is &#x0003e;20.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> Recombinant vCPH is able to hydroxylate various
proline-rich
peptide sequences.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Different peptide
sequences were assayed to determine how the sequence affects the rate
of product formation. These were variants of the (PAPK)<sub><italic>n</italic></sub> sequence determined to be preferable substrates
for vCPH by Eriksson et al.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). Initially, we
analyzed (PAPK)<sub><italic>n</italic></sub>, where <italic>n</italic> = 2 and 5, by MALDI mass spectrometry. We found that with <italic>n</italic> = 2, two hydroxylations were observed (a mass shift from
806.7 to 838.7 Da), whereas for <italic>n</italic> = 5, up to eight
hydroxylations were observed (a mass shift from 1984.1 to 2111.5 Da).
Under the same conditions, (PAPP)<sub>5</sub> underwent up to four
hydroxylations (a mass shift from 1851.6 to 1915.2 Da), whereas (PEPV)<sub>5</sub> was not hydroxylated (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). Eriksson et al.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> previously
showed that only &#x0201c;internal&#x0201d; prolines (i.e., not those
at the N- and C-terminal positions) were being hydroxylated. This
is likely the case for the (PAPK)<sub><italic>n</italic></sub> and
(PAPP)<sub>5</sub> substrates. However, as (PEPV)<sub>5</sub> was
not hydroxylated, this suggests specificity for only certain proline-rich
peptides.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>MALDI-TOF spectra showing peptide hydroxylation by vCPH. The plots
show the change in mass of peptides after they were incubated with
vCPH. The top plots show the masses of the peptides after overnight
incubations, and the bottom plots show the initial masses of the peptides.
The number of oxygen molecules added to each peptide is indicated.
Assay conditions: 4 &#x003bc;M vCPH, 160 &#x003bc;M ascorbate, 15 mM 2-OG,
1 &#x003bc;M FeSO<sub>4</sub>, and 100 &#x003bc;M peptide in 50 mM Tris-HCl
buffer (pH 7.5). Reaction mixtures were incubated at 37 &#x000b0;C and
reactions quenched with methanol.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0005" id="gr4" position="float"/></fig><p>Other potential substrates were then tested with vCPH, with
a view
of identifying a good substrate undergoing only a single hydroxylation
suitable for kinetic analyses. One of the hydroxylation sites in (PAPK)<sub>2</sub> was blocked by introduction of a <italic>trans</italic>-4-hydroxyproline
residue (Hyp) to give PAPKHypAPK; this peptide was found to undergo
only a single hydroxylation (a mass shift from 822.8 to 838.8 Da).
Subsequent studies employed longer peptides to allow adequate binding,
but also undergoing a single hydroxylation as shown by mass spectrometry.
These were (GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub> and (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub> (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>).</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Product formation of the reaction of vCPH with
three peptide substrates.
Plots of the reaction of vCPH in complex with Fe(II), 2-OG, and peptide
with oxygen are shown. Three peptide substrates were assayed and the
samples chemically quenched with 1% TFA at different time points.
Quenched samples were analyzed to determine the percentage of peptide
hydroxylation using <xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref> (A) and levels of succinate (B) during the reaction. The data were
fitted to a single-exponential function shown as a red line <xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>. Final conditions: 800
&#x003bc;M vCPH, 800 &#x003bc;M FeSO<sub>4</sub>, 1 mM 2-OG, and 1 mM
peptide in 100 mM HEPES (pH 7.5) under anaerobic conditions at 5 &#x000b0;C,
reacted with O<sub>2</sub>-saturated buffer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0006" id="gr5" position="float"/></fig><p>The dissociation constants of the vCPH&#x02013;peptide complexes
were determined by monitoring tryptophan fluorescence quenching upon
addition of peptide substrate to a solution of vCPH in complex with
Fe(II). The peptides studied in detail were all found to bind tightly
to vCPH as they had dissociation constants between 1.6 and 2.9 &#x003bc;M
(<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). This suggests
that only stretches of hydrophobic residues rather than prolines are
necessary as the glycine-rich sequence, (GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub>, had a dissociation constant similar to those of proline-rich
sequences.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Kinetic Parameters of Product Formation
in vCPH</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">(PAPK)<sub>3</sub></th><th style="border:none;" align="center">(GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub></th><th style="border:none;" align="center">(HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub></th></tr></thead><tbody><tr><td colspan="4" style="border:none;" align="center">Rapid Quench MS
Measurements</td></tr><tr><td style="border:none;" align="left">rate of peptide hydroxylation
(s<sup>&#x02013;1</sup>)</td><td style="border:none;" align="left">ND</td><td style="border:none;" align="left">0.102&#x000a0;&#x000b1;&#x000a0;0.022</td><td style="border:none;" align="left">0.84&#x000a0;&#x000b1;&#x000a0;0.11</td></tr><tr><td style="border:none;" align="left">rate of succinate
formation (s<sup>&#x02013;1</sup>)</td><td style="border:none;" align="left">0.052&#x000a0;&#x000b1;&#x000a0;0.060</td><td style="border:none;" align="left">0.047&#x000a0;&#x000b1;&#x000a0;0.005</td><td style="border:none;" align="left">0.77&#x000a0;&#x000b1;&#x000a0;0.26</td></tr><tr><td colspan="4" style="border:none;" align="center">Tryptophan Fluorescence
Quenching Measurements</td></tr><tr><td style="border:none;" align="left">dissociation constant
(&#x003bc;M)</td><td style="border:none;" align="left">1.60&#x000a0;&#x000b1;&#x000a0;0.26</td><td style="border:none;" align="left">1.65&#x000a0;&#x000b1;&#x000a0;0.33</td><td style="border:none;" align="left">2.86&#x000a0;&#x000b1;&#x000a0;0.27</td></tr></tbody></table></table-wrap><p>The rate of product formation
in the reaction catalyzed by vCPH
using three different peptides [(PAPK)<sub>3</sub>, (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub>, and (GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub>] was determined by rapid quench-flow experiments. Samples
were collected when the reaction of vCPH&#x000b7;Fe(II)&#x000b7;2-OG with
peptide and oxygen was chemically quenched with 1% trifluoroacetic
acid (TFA) at various time points. Hydroxylated peptide formed was
quantified by MALDI-TOF MS and succinate generated by LC&#x02013;MS
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). The rate
constants of peptide hydroxylation and succinate formation are listed
in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>. Rate constants
for the (PAPK)<sub>3</sub> peptide were not measured because of the
multiple hydroxylation sites on the peptide, but rates were obtained
for succinate formation.</p><p>The rate constant for hydroxylation
of (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub> was determined
to be faster than that for the (GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub> peptide (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A), suggesting that (hydroxylated) proline-rich
peptides are preferable to glycine-rich peptides as vCPH substrates.
The rate of peptide hydroxylation and the rate of succinate formation
are similar for both peptides (GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub> and (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub> (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). This is consistent
with the consensus mechanism, which implies that hydroxylation is
coupled to 2-OG decarboxylation (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p></sec><sec id="sec3.4"><title>Characterization of the MLCT Complex in vCPH</title><p>The dissociation
constant for the vCPH&#x02013;2OG complex in the presence of Fe(II)
was determined by measuring absorbance changes at 520 nm. These absorbance
changes are associated with the MLCT complex (&#x003b5;<sub>520</sub> = 250 M<sup>&#x02013;1</sup> cm<sup>&#x02013;1</sup><sup><xref ref-type="bibr" rid="ref9">9</xref></sup>). A broad spectral feature was observed over 400&#x02013;700
nm after 2-OG was added to vCPH with an absorbance maximum at approximately
520 nm (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A).
The values at 520 nm were plotted against 2-OG concentration and fitted
to <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref> to determine
a <italic>K</italic><sub>d</sub> for the 2-OG&#x02013;vCPH complex
(746 &#x000b1; 128 &#x003bc;M). This value differs from that reported by
Hoffart et al. (27 &#x000b1; 6 &#x003bc;M). However, the agreement of our
value with the value determined by tryptophan fluorescence (681 &#x000b1;
128 &#x003bc;M) (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>) indicates a weaker binding mode may be at play.</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Kinetic Parameters of MLCT Complex
Formation in vCPH</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center" char="&#x000b1;"><italic>K</italic><sub>d</sub> (&#x003bc;M)</th><th style="border:none;" align="center" char="&#x000b1;"><italic>k</italic><sub>on</sub> (mM<sup>&#x02013;1</sup>&#x000a0;s<sup>&#x02013;1</sup>)</th><th style="border:none;" align="center" char="&#x000b1;"><italic>k</italic><sub>off</sub> (s<sup>&#x02013;1</sup>)</th></tr></thead><tbody><tr><td style="border:none;" align="left">520 nm absorbance measurements</td><td style="border:none;" align="char" char="&#x000b1;">746&#x000a0;&#x000b1;&#x000a0;128</td><td style="border:none;" align="char" char="&#x000b1;">17.8&#x000a0;&#x000b1;&#x000a0;5.0</td><td style="border:none;" align="char" char="&#x000b1;">65.8&#x000a0;&#x000b1;&#x000a0;30.9</td></tr><tr><td style="border:none;" align="left">tryptophan quenching
measurements</td><td style="border:none;" align="char" char="&#x000b1;">681&#x000a0;&#x000b1;&#x000a0;128</td><td style="border:none;" align="char" char="&#x000b1;">19.8&#x000a0;&#x000b1;&#x000a0;0.9</td><td style="border:none;" align="char" char="&#x000b1;">31.6&#x000a0;&#x000b1;&#x000a0;1.4</td></tr></tbody></table></table-wrap><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Kinetic studies of MLCT complex formation.
(A) Titration of 2-OG
into a solution of vCPH in complex with Fe(II). The left-hand plot
shows the difference spectra of vCPH after increasing concentrations
of 2-OG are added to a vCPH Fe(II) solution. Spectra shown are samples
with 0&#x02013;5 mM 2-OG present. The right-hand plot shows the absorbance
values at 520 nm vs 2-OG concentration. The data were fitted to the
Morrison equation (<xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>), which is shown as a black line. Conditions: 150 &#x003bc;M vCPH,
200 &#x003bc;M FeSO<sub>4</sub> in 0.5 M NaCl, 50 mM Tris, 10% (v/v)
glycerol buffer (pH 7.6) at 25 &#x000b0;C under anaerobic conditions.
(B) Dependence of the observed rate constant on the concentration
of 2-OG during MLCT complex formation. The left-hand plot shows single-wavelength
transients at 520 nm for the formation of the MLCT complex after vCPH,
in complex with Fe(II), is mixed with 2-OG in a stopped flow. The
data were fitted to an exponential equation (<xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>). The right-hand plot shows the observed
rate constants of formation at 520 nm of the first faster phase vs
2-OG concentration. Final conditions: 200 &#x003bc;M vCPH, 250 &#x003bc;M
FeSO<sub>4</sub> in 50 mM Tris, and 0.5 M NaCl (pH 7.6) at 10 &#x000b0;C
mixed with varying concentrations of 2-OG under anaerobic conditions.
(C) 2-OG concentration dependence of the transient state kinetics
of vCPH tryptophan quenching upon MLCT complex formation. The top
left-hand plot is an example of transients measured when vCPH in complex
with Fe(II) was mixed with 2-OG in the stopped flow. The data were
fitted to an exponential equation (<xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>). The top right-hand plot shows the observed rate
constants of tryptophan quenching for the first faster phase vs 2-OG
concentration, and the bottom plot shows their respective amplitudes.
Final conditions: 5 &#x003bc;M vCPH, 20 &#x003bc;M FeSO<sub>4</sub> mixed
with varying concentrations of 2-OG in a 50 mM Tris, 0.5 mM NaCl buffer
(pH 7.6) under anaerobic conditions at 10 &#x000b0;C. Samples were excited
at 295 nm, and fluorescence at 350 nm was measured.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0007" id="gr6" position="float"/></fig><p>The transient state kinetics of MLCT complex formation
were investigated
by stopped-flow spectroscopy. Absorbance changes at 520 nm were measured
after vCPH&#x000b7;Fe(II) was mixed with varying concentrations of 2-OG
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B). A single-
or double-exponential reaction trace was observed (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B). <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B shows the observed rate constants calculated
from the single-wavelength traces of the first (faster) phase plotted
against 2-OG concentration. The data show a linear relationship between
2-OG concentration and the observed rate constant, confirming that
this first phase is a second-order process. The data were fitted to
a linear equation (<xref rid="eq4" ref-type="disp-formula">eq <xref rid="eq4" ref-type="disp-formula">4</xref></xref>) to calculate the <italic>k</italic><sub>on</sub> and <italic>k</italic><sub>off</sub> values, which were 17.8 &#x000b1; 5.0 mM<sup>&#x02013;1</sup> s<sup>&#x02013;1</sup> and 65.8 &#x000b1; 30.9 s<sup>&#x02013;1</sup>, respectively (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). The rates of the slower phase were found to be independent of
2-OG concentration and were in the range of 2&#x02013;20 s<sup>&#x02013;1</sup> (data not shown). Experimental difficulties associated with absorption
measurements {poor signal-to-noise ratio due to protein precipitation
of high concentrations of the vCPH&#x000b7;Fe(II)&#x000b7;2OG [or vCPH&#x000b7;Fe(II)]
complex, combined with a low extinction coefficient} meant absorbance
amplitude values could not be determined and multiple measurements
per 2-OG concentration were not possible, resulting in the lack of
error bars in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B. However, these difficulties were not experienced in the rapid
quench experiments, potentially because of the presence of substrate,
allowing higher protein concentrations to be used. As an alternative
method, changes in tryptophan fluorescence were measured to determine
whether they report on 2-OG binding. A single- or double-exponential
trace of fluorescence quenching was observed when the vCPH&#x000b7;Fe(II)
complex was mixed with 2-OG (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>C). The first exponential rate constants had a linear
dependence on 2-OG concentration, similar to absorbance measurements.
The <italic>k</italic><sub>on</sub> and <italic>k</italic><sub>off</sub> rates of this first exponential phase (19.8 &#x000b1; 0.9 mM<sup>&#x02013;1</sup> s<sup>&#x02013;1</sup> and 31.6 &#x000b1; 1.4 s<sup>&#x02013;1</sup>,
respectively) were comparable to those determined by absorbance measurements
(<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>), indicating
that tryptophan quenching also reports on 2-OG binding. Also, the
dissociation constant measured by tryptophan quenching (680 &#x000b1;
130 &#x003bc;M) (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>) was comparable to the value presented in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A. The amplitudes of the stopped-flow transients
also did not appear to saturate until &#x02248;2 mM 2-OG (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>C), which would indicate
incomplete binding at lower concentrations, consistent with 2-OG binding
weakly to vCPH. Despite difficulties in measuring absorbance changes
associated with the MLCT complex, these data suggest a multiple-step
mechanism for 2-OG binding.</p></sec></sec><sec id="sec4"><title>Discussion</title><sec id="sec4.1"><title>Comparison
between the Structure of vCPH and Those of Structural
Homologues</title><p>The crystal structure of a viral collagen prolyl
hydroxylase has been determined for the first time (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). vCPH contains many of the
structural features conserved in other Fe(II)- and 2-OG-dependent
dioxygenases, including the DSBH motif and iron binding residues<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). To date, the crystal structures of five prolyl-4-hydroxylases,
including vCPH, have been determined. These are human HIF prolyl hydroxylase
2 (PHD2),<sup><xref ref-type="bibr" rid="ref41">41</xref></sup><italic>C. reinhardtii</italic> prolyl hydroxylase (Cr-P4H),<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> a prolyl
hydroxylase from <italic>Bacillus anthracis</italic> (anthrax P4H),<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> and a <italic>Pseudomonas aeruginosa</italic> prolyl hydroxylase domain-containing protein (PPHD).<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> The structure of a human ribosomal prolyl-3-hydroxylase,
OGFOD1 (Tpa1p in <italic>Saccharomyces cerevisiae</italic>), has also
been reported, but this is more distantly related to the prolyl-4-hydroxylases.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> vCPH superimposes well with the prolyl-4-hydroxylase proteins, and
the DSBH fold, &#x003b1;1, &#x003b2;1, &#x003b2;2, and &#x003b1;2 of vCPH
are in positions similar to those of the topologically similar regions
in these three enzymes (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A). These other prolyl hydroxylases often have N-terminal
extensions and differences in loops from the core DSBH motif.</p><fig id="fig7" position="float"><label>Figure 7</label><caption><p>Structural
comparison of the prolyl-4-hydroxylases. (A) Superimposition
of four available crystal structures of prolyl-4-hydroxylases. The
core DSBH is colored gray, and the differing structural motifs are
colored. vCPH is colored cyan, Cr-P4H magenta (PDB entry 2JIG), anthrax P4H green
(PDB entry 3ITQ), and PHD2 yellow (PDB entry 2G19). Colored text refers to structures defined
by the colors. (B) Comparison of vCPH (cyan) and Cr-P4H (magenta)
(PDB entry 2JIG). Tyr149 from vCPH has been omitted for the sake of clarity. 2-OG
from vCPH is colored blue and 2-OG from Cr-P4H red. (C) Comparison
of vCPH (cyan) and PHD2 (yellow) (PDB entry 3OUJ). 2-OG from vCPH
is colored blue and 2-OG from PHD2 brown. Water molecules are shown
as small cyan, magenta, and yellow spheres for vCPH, Cr-P4H, and PHD2,
respectively. (D) Structural alignment of the sequences of the prolyl-4-hydroxylases.
Sequences were aligned by their secondary structures, using the Promal3D
server. The secondary structure of vCPH is labeled above the sequence.
&#x003b2;-Sheets are shown as red arrows and &#x003b1;-helices as blue
squares. Residues involved in iron, 2-OG, and peptide binding are
labeled as triangles, circles, and squares, respectively. Underlined
residues in the &#x003b2;II&#x02212;&#x003b2;III loop indicate the conserved
D/E-X-X-N/D motif. Key: &#x003b1;-helix, h; &#x003b2;-strand, e; conserved
amino acids in bold and uppercase letters; aliphatic, <italic>l</italic>; aromatic, <italic>@</italic>; hydrophobic, <italic>h</italic>;
alcohol, o; polar residues, p; tiny, t; small, s; bulky residues,
b; positively charged, +; negatively charged, &#x02212;; charged, c.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0008" id="gr7" position="float"/></fig><p>Unique to vCPH, in 2-OG oxygenase
structures determined to date,
is a disulfide bond formed between a region N-terminal to &#x003b2;1
and the &#x003b1;2&#x02212;&#x003b2;I loop (Cys47 and Cys129) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). In Cr-P4H and
anthrax P4H, this N-terminal to &#x003b2;1 region is shorter and contains
an &#x003b1;-helix, and in PHD2, this is a longer loop that interacts
with the C-terminal helix of PHD2. It is possible that this disulfide
bond is present in vCPH to give stability to this region, which is
unnecessary in the shorter loop regions of Cr-P4H and anthrax P4H.
Stability of this equivalent region in PHD2 is provided by interactions
of the extended loop with the C-terminal helix. Another disulfide
bond is present in the &#x003b2;II&#x02212;&#x003b2;III loop (Cys158 and
Cys162). This bond should stabilize the loop region. In Cr-P4H, this
loop is stabilized by hydrogen bonds between Asp149 and Asn152, which
are conserved in other prolyl hydroxylases (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D).<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> In anthrax
P4H, this region contains an &#x003b1;-helix and hydrogen bonds between
residues of the loop, which would stabilize the region.</p></sec><sec id="sec4.2"><title>Comparison
of the 2-OG Binding Site with Homologues</title><p>The 2-OG binding
site in vCPH is similar to that of other prolyl
C-4 hydroxylases. The majority of residues that form hydrogen bonds
to 2-OG in vCPH are conserved in Cr-P4H (Thr186, Lys231, Tyr143, Gln139,
and Tyr149 in vCPH) (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>B,D). Exceptions include Asn235 in vCPH, which is Thr241 in
Cr-P4H. However, regardless of the residue in this position, it still
forms hydrogen bonds with the C1 carboxylate of 2-OG [2,4-pyridine-dicarboxylate
(PDCA) in Cr-P4H]. Gln130 in Cr-P4H is hydrogen bonded to the main
chain atoms of Ala153 in the &#x003b2;II&#x02212;&#x003b2;III loop, which
is folded over the active site, whereas the equivalent residue Gln139
in vCPH forms an interaction with 2-OG via a water molecule (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>B). It is possible
that this hydrogen bond in vCPH will resemble the equivalent residue
in Cr-P4H if the topologically similar loop region in vCPH folds over
the active site. The active site of vCPH also shares many conserved
residues with PHD2 (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>C). However, they have significantly different <italic>K</italic><sub>d</sub> values for the 2-OG&#x02013;enzyme complex under comparable
conditions. The value calculated for vCPH was 746 &#x000b1; 128 &#x003bc;M
(<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>), which is
much higher than that of PHD2 (&#x02264;2 &#x003bc;M).<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup></p><p>Upon comparison of the structures of vCPH and PHD2, the structural
origin of the variation in the dissociation constant for the 2-OG&#x02013;enzyme
is not clear. However, one difference is a different basic residue
coordinating C5 of 2-OG (Lys231 in vCPH, Arg383 in PHD2) (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>C), and studies of
a PHD2 R383K variant have shown weaker binding of 2-OG to the PHD2&#x02013;Fe(II)
complex.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> This may explain the weaker
binding of 2-OG in vCPH compared to that in the structurally similar
PHD2. The active site of PHD2 is proposed to be specifically tailored
for the tight binding of 2-OG and slow reactivity with oxygen.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Further comparative studies of vCPH and PHD2
might shed light on why PHD2 is so slow to react with oxygen.</p><p>Tyr149 in the Mn-bound structure of vCPH is flipped out from the
active site (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). When 2-OG is bound, this residue flips toward the active site
where it forms hydrogen bonds with 2-OG via a water molecule. The
adjacent Tyr150 residue also has a similar flipping movement. This
is similar to that observed for the equivalent residues in Cr-P4H.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> This movement has been suggested to modulate
loop movements upon substrate binding. Tyr150 in Mn-bound vCPH is
in the position where the &#x003b1;1&#x02212;&#x003b2;2 loop would be expected
when the peptide substrate is bound. When this residue flips out,
upon 2-OG binding, it may allow the loop movement to occur and facilitate
peptide substrate binding. This tyrosine residue is conserved in other
prolyl hydroxylases (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D), and this structure shows this residue is a potential &#x0201c;conformational
switch&#x0201d; as also suggested by Koski and colleagues.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup></p><p>2-OG is bound to the Zn (substituting
for Fe) with the 1-carboxylate <italic>trans</italic> to the distal
histidine (His221) and the 2-oxo group <italic>trans</italic> to the
aspartate residue (Asp154) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C). This mode of binding is
observed in crystal structures of other family members, including
PHD2, carbapenem synthase (CarC),<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> and
anthocyanidin synthase (ANS).<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> The positioning
of 2-OG in this manner means that the unoccupied coordination site
on iron, where oxygen could bind, is oriented away from the peptide
substrate. Several suggestions of how the oxygen becomes oriented
toward the substrate during catalysis have been discussed.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> One of these possibilities includes
a rearrangement of the C-1 carboxylate of the 2-OG molecule. It has
been discussed that in Cr-P4H a change in position of the 2-OG molecule
to a position where oxygen binds <italic>trans</italic> to the axial
histidine would require the movement of the side chain of Tyr140.
It is possible that this might apply to vCPH as Tyr149 is in a position
topologically similar to that of Tyr140.</p></sec><sec id="sec4.3"><title>Significance of the Kinetics
of MLCT Complex Formation in vCPH</title><p>Aspects of the catalytic
cycle of vCPH were analyzed using stopped-flow
spectroscopy, including using a peptide that undergoes a single hydroxylation.
Specifically, absorbance changes at 520 nm upon mixing of vCPH with
2-OG report on 2-OG binding (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B). Absorbance data were difficult to obtain because
of enzyme precipitation at the required high enzyme concentrations
(&#x0003e;200 &#x003bc;M) for observation of the relatively weak absorption
signals. Consequently, tryptophan fluorescence was used to measure
2-OG binding at a substantially reduced vCPH concentration (5 &#x003bc;M)
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>C). Tryptophan
fluorescence changes mirrored data obtained by absorbance measurements
suggesting that both signals observed in stopped-flow studies report
on 2-OG binding (i.e., MLCT complex formation) (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). This is further supported by the presence
of Trp237 in the 2-OG binding pocket, which would be affected by ligand
binding (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C).
A two-step binding mechanism in which a faster transient developed
at the higher concentrations of 2-OG assayed was identified (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B,C). The faster
kinetic phase was determined to have second-order kinetics (<italic>k</italic><sub>on</sub> and <italic>k</italic><sub>off</sub> values
17.8 &#x000b1; 5.0 mM<sup>&#x02013;1</sup> s<sup>&#x02013;1</sup> and 65.8
&#x000b1; 30.9 s<sup>&#x02013;1</sup>, respectively, for absorbance changes
and 19.8 &#x000b1; 0.9 mM<sup>&#x02013;1</sup> s<sup>&#x02013;1</sup> and
31.6 &#x000b1; 1.4 s<sup>&#x02013;1</sup>, respectively, for tryptophan
fluorescence measurements). However, the slower phase obeyed first-order
kinetics as the observed rate constants were independent of 2-OG concentration.
These data are consistent with a model in which 2-OG binds vCPH initially
in a 2-OG concentration-dependent manner. A slower first-order active
site rearrangement occurs after this initial binding phase (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>), where <italic>k</italic><sub>1</sub> and <italic>k</italic><sub>2</sub> describe
the <italic>k</italic><sub>on</sub> and <italic>k</italic><sub>off</sub> values, respectively.</p><fig id="sch1" position="float"><label>Scheme 1</label><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2015-007898_0011" id="GRAPHIC-d944e2114-autogenerated" position="float"/></fig><p>Rate constant <italic>k</italic><sub>3</sub> can be described by
the observed rate constants measured from the second (slower) phase
that was independent of 2-OG concentration. A similar experiment conducted
on TauD determined that binding of 2-OG to the enzyme&#x000b7;Fe(II)
complex was also multiphasic.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Price et
al. showed evidence that this complex kinetic scheme arises from multiple
conformational states of the enzyme.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Other
studies of Fe(II)- and 2-OG-dependent dioxygenases have shown that
the DSBH core is more conformationally flexible, in particular in
the apo state (i.e., without 2OG or metal) of DNA demethylase AlkB<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> and PHD2.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> It seems likely that similar
conformational flexibility is a feature of the multistep mechanism
for binding of 2-OG to vCPH.</p></sec><sec id="sec4.4"><title>Mode of Peptide Binding in vCPH</title><p>Loop regions close
to the active site are important in substrate binding in other prolyl-4-hydroxylases.<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> Molecular dynamics simulations demonstrate that peptide binding
facilitates formation of a &#x0201c;closed&#x0201d; conformation of
vCPH (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). This
closed conformation has also been observed in Cr-P4H and PHD2. However,
the &#x003b2;II&#x02212;&#x003b2;III loop in PHD2 is shorter than the equivalent
in vCPH and does not directly participate in substrate binding at
the active site.</p><p>The &#x003b2;II&#x02212;&#x003b2;III loop contains
a conserved D/E-X-X-N/D motif present in other collagen prolyl hydroxylases<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D), which has been shown to maintain the structure of the
loop region via a hydrogen bonding network.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> This motif is also present in vCPH (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D), suggesting a similar role for these residues.
However, these simulations do not show this hydrogen bonding network
is present. Another conserved sequence of residues, the D/N-X-X-S/T-G
motif, present in the equivalent &#x003b1;1&#x02212;&#x003b2;2 loop region
in various other collagen prolyl hydroxylases is not present in vCPH
(<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D).<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> This sequence was shown to be important in peptide
binding in Cr-P4H, and its absence in vCPH suggests the mode of peptide
binding differs from those of other collagen prolyl hydroxylases.</p><p>Hydrophobic residues surrounding the hydroxylated proline residue
in the Cr-P4H peptide-bound structure are conserved in vCPH (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D). These residues
are Val81 (Val79 in Cr-P4H) and Gly82 (Val80 in Cr-P4H), which may
serve the same function in vCPH. The peptide binding groove is also
similar to that of Cr-P4H, as most residues in vCPH are conserved
in Cr-P4H apart from Asp157 in vCPH, which is Gly128 in Cr-P4H, and
Arg239, which is His245 in Cr-P4H (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>D).<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> This indicates
that the prolyl hydroxylases may have a conserved binding groove that
is able to accommodate proline-rich peptides via hydrophobic interactions.</p><p>Rapid quench mass spectrometry indicates that, of the peptides
tested, (GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub> was found to have
a rate of hydroxylation lower than that of (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub>. This suggests a preference for proline residues in the sequences
rather than glycine residues. However, significant differences in
the dissociation constants of these peptides are not observed. Longer
peptides have been shown to be better substrates with lower <italic>K</italic><sub>m</sub> and higher <italic>V</italic><sub>max</sub> values.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> As there are likely several
hydrophobic interactions with the peptide and the peptide binding
groove, it is likely that longer peptides form additional hydrophobic
interactions leading to tighter binding. Rate constants for peptide
hydroxylation are similar to those for succinate formation for peptides
(GAGK)<sub>2</sub>PAGK(GAGK)<sub>2</sub> and (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub>. This agrees with the proposed mechanism
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) for the
vCPH reaction cycle, in which these two processes are tightly coupled,
and the fact that in the case of vCPH there is minimal accumulation
of intermediate species between succinate formation and peptide hydroxylation.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> The rates of substrate hydroxylation
and succinate formation for vCPH are much faster than those of its
homologue, PHD2<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> [approximately 43- and
65-fold increases, respectively for (HypAHypK)<sub>2</sub>PAHypK(HypAHypK)<sub>2</sub> in vCPH]. The rearrangement of the 2-OG molecule during catalysis
and a metal-coordinated water molecule stabilized by hydrogen bonding
with the metal binding Asp residue have both been proposed as factors
contributing to the slow reaction of PHD2 with oxygen.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> Relatively fast activation by
oxygen in vCPH may be caused by differences in the structure. Asp315
of PHD2 interacts with both the active site Fe(II) and a Fe(II)-coordinated
water molecule.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> This water is strongly
ligated in PHD2, and a D315E variant with a weaker interaction with
this water molecule, showed more rapid kinetics with respect to oxygen,
possibly as a result of more facile H<sub>2</sub>O release to allow
oxygen binding. Whether such a strongly ligated water molecule is
present in vCPH is not certain at present, but the crystal structure
reveals no such water molecule present in the Zn(II)- and 2-OG-bound
structure. The lack of a strongly bound water molecule in a Zn(II)-bound
vCPH could be another potential factor responsible for the faster
peptide hydroxylation. It is, however, unclear whether this is the
case in a Fe(II)-bound structure. Further studies of vCPH could elucidate
why the activation of oxygen in PHD2 is slow relative to other prolyl
hydroxylases.</p></sec><sec id="sec4.5"><title>Concluding Remarks</title><p>The crystal structure
of vCPH and
analysis of key aspects of the enzyme reaction cycle add to the growing
body of structural understanding of the Fe(II)- and 2-OG-dependent
prolyl hydroxylases. The study reveals that vCPH is an excellent and
accessible model for mechanistic analysis of the growing family of
prolyl hydroxylase enzymes, and more broadly the Fe(II)- and 2-OG-dependent
dioxygenase superfamily of enzymes.</p></sec></sec></body><back><notes notes-type="accession-codes" id="notes-55"><title>Accession Codes</title><p>All coordinates
and data have been deposited as Protein Data Bank entries 5C5T and 5C5U.</p></notes><notes notes-type="" id="notes-2"><title>Author Contributions</title><p>J.E.L. purified
and crystallized vCPH, performed the majority of kinetic experiments,
analyzed the crystal structures, and wrote the paper. C. Levy collected
and processed the crystallography data and generated the crystal structure
models. L.O.J. performed molecular modeling simulations of vCPH. H.T.
and J.E.L. performed the rapid quench assays and MS product detection.
E.F. coordinated this aspect of the study and contributed to manuscript
preparation. C. Loenarz purified vCPH, designed, synthesized, and
purified peptides, and performed peptide hydroxylation assays. S.J.
synthesized peptides and performed peptide hydroxylation assays. S.H.
assisted in analyzing the MLCT complex binding model. C.J.S. and N.S.S.
conceived and coordinated the study and wrote the paper. All authors
analyzed the results and approved the final version of the manuscript.</p></notes><notes notes-type="funding-statement" id="notes-1"><p>This work was
supported by the Biotechnology and Biological Sciences Research Council
(BBSRC) (Grant BB/M017702/1), a Royal Society Dorothy Hodgkin Fellowship
(E.F.), a L&#x02019;Oreal-UNESCO For Women In Science Fellowship (E.F.),
a Clarendon-St Hugh&#x02019;s College-W. Louey Scholarship (H.T.),
a Leverhulme Fellowship (C.L.), and the Wellcome Trust. N.S.S. is
an Engineering and Physical Sciences Research Council (EPSRC) Established
Career Fellow (EP/J02019211).</p></notes><notes notes-type="COI-statement" id="NOTES-d944e2276-autogenerated"><p>The authors declare
no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We thank Diamond Light Source for access to beamline i04-1
(Proposal MX7146) that contributed to the results presented here.</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term>2-OG</term><def><p>2-oxoglutarate</p></def></def-item><def-item><term>DSBH</term><def><p>double-stranded &#x003b2;-helix</p></def></def-item><def-item><term>LC&#x02013;MS</term><def><p>liquid
chromatography&#x02013;mass spectrometry</p></def></def-item><def-item><term>MALDI-TOF MS</term><def><p>matrix-assisted laser desorption
ionization time-of-flight mass spectrometry</p></def></def-item><def-item><term>MLCT</term><def><p>metal to ligand charge transfer</p></def></def-item><def-item><term>PBCV-1</term><def><p><italic>P. bursaria</italic> Chlorella Virus-1</p></def></def-item><def-item><term>PHD</term><def><p>prolyl hydroxylase domain proteins</p></def></def-item><def-item><term>vCPH</term><def><p>truncated viral collagen prolyl hydroxylase.</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Hausinger</surname><given-names>R. P.</given-names></name> (<year>2004</year>) <article-title>FeII/alpha-ketoglutarate-dependent
hydroxylases and related enzymes</article-title>. <source>Crit. Rev.
Biochem. Mol. Biol.</source>
<volume>39</volume>, <fpage>21</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1080/10409230490440541</pub-id>.<pub-id pub-id-type="pmid">15121720</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2008</year>) <article-title>Expanding chemical biology of 2-oxoglutarate
oxygenases</article-title>. <source>Nat. Chem. Biol.</source>
<volume>4</volume>, <fpage>152</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio0308-152</pub-id>.<pub-id pub-id-type="pmid">18277970</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2011</year>) <article-title>Physiological
and biochemical aspects of hydroxylations
and demethylations catalyzed by human 2-oxoglutarate oxygenases</article-title>. <source>Trends Biochem. Sci.</source>
<volume>36</volume>, <fpage>7</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2010.07.002</pub-id>.<pub-id pub-id-type="pmid">20728359</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Hewitson</surname><given-names>K. S.</given-names></name>; <name><surname>Granatino</surname><given-names>N.</given-names></name>; <name><surname>Welford</surname><given-names>R. W. D.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2005</year>) <article-title>Oxidation by 2-oxoglutarate oxygenases: non-haem iron
systems in catalysis and signalling</article-title>. <source>Philos.
Trans. R. Soc., A</source>
<volume>363</volume>, <fpage>807</fpage>&#x02013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1098/rsta.2004.1540</pub-id>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Neary</surname><given-names>J. M.</given-names></name>; <name><surname>Powell</surname><given-names>A.</given-names></name>; <name><surname>Gordon</surname><given-names>L.</given-names></name>; <name><surname>Milne</surname><given-names>C.</given-names></name>; <name><surname>Flett</surname><given-names>F.</given-names></name>; <name><surname>Wilkinson</surname><given-names>B.</given-names></name>; <name><surname>Smith</surname><given-names>C. P.</given-names></name>; <name><surname>Micklefield</surname><given-names>J.</given-names></name> (<year>2007</year>) <article-title>An asparagine
oxygenase (AsnO) and a 3-hydroxyasparaginyl phosphotransferase (HasP)
are involved in the biosynthesis of calcium-dependent lipopeptide
antibiotics</article-title>. <source>Microbiology</source>
<volume>153</volume>, <fpage>768</fpage>&#x02013;<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.2006/002725-0</pub-id>.<pub-id pub-id-type="pmid">17322197</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Tsukada</surname><given-names>Y.</given-names></name>; <name><surname>Fang</surname><given-names>J.</given-names></name>; <name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name>; <name><surname>Warren</surname><given-names>M. E.</given-names></name>; <name><surname>Borchers</surname><given-names>C. H.</given-names></name>; <name><surname>Tempst</surname><given-names>P.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name> (<year>2005</year>) <article-title>Histone demethylation
by a family
of JmjC domain-containing proteins</article-title>. <source>Nature</source>
<volume>439</volume>, <fpage>811</fpage>&#x02013;<lpage>816</lpage>. <pub-id pub-id-type="doi">10.1038/nature04433</pub-id>.<pub-id pub-id-type="pmid">16362057</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Trewick</surname><given-names>S. C.</given-names></name>; <name><surname>Henshaw</surname><given-names>T. F.</given-names></name>; <name><surname>Hausinger</surname><given-names>R. P.</given-names></name>; <name><surname>Lindahl</surname><given-names>T.</given-names></name>; <name><surname>Sedgwick</surname><given-names>B.</given-names></name> (<year>2002</year>) <article-title>Oxidative
demethylation by Escherichia coli AlkB directly reverts DNA base damage</article-title>. <source>Nature</source>
<volume>419</volume>, <fpage>174</fpage>&#x02013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1038/nature00908</pub-id>.<pub-id pub-id-type="pmid">12226667</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Mishina</surname><given-names>Y.</given-names></name>; <name><surname>He</surname><given-names>C.</given-names></name> (<year>2006</year>) <article-title>Oxidative dealkylation DNA repair mediated by the mononuclear non-heme
iron AlkB proteins</article-title>. <source>J. Inorg. Biochem.</source>
<volume>100</volume>, <fpage>670</fpage>&#x02013;<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2005.12.018</pub-id>.<pub-id pub-id-type="pmid">16469386</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Hoffart</surname><given-names>L. M.</given-names></name>; <name><surname>Barr</surname><given-names>E. W.</given-names></name>; <name><surname>Guyer</surname><given-names>R. B.</given-names></name>; <name><surname>Bollinger</surname><given-names>J. M.</given-names></name>; <name><surname>Krebs</surname><given-names>C.</given-names></name> (<year>2006</year>) <article-title>Direct spectroscopic detection of
a C-H-cleaving high-spin Fe(IV)
complex in a prolyl-4-hydroxylase</article-title>. <source>Proc. Natl.
Acad. Sci. U. S. A.</source>
<volume>103</volume>, <fpage>14738</fpage>&#x02013;<lpage>14743</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0604005103</pub-id>.<pub-id pub-id-type="pmid">17003127</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Price</surname><given-names>J. C.</given-names></name>; <name><surname>Barr</surname><given-names>E. W.</given-names></name>; <name><surname>Tirupati</surname><given-names>B.</given-names></name>; <name><surname>Bollinger</surname><given-names>J. M.</given-names></name>; <name><surname>Krebs</surname><given-names>C.</given-names></name> (<year>2003</year>) <article-title>The first direct characterization of a high-valent iron intermediate
in the reaction of an alpha-ketoglutarate-dependent dioxygenase: a
high-spin FeIV complex in taurine/alpha-ketoglutarate dioxygenase
(TauD) from Escherichia coli</article-title>. <source>Biochemistry</source>
<volume>42</volume>, <fpage>7497</fpage>&#x02013;<lpage>7508</lpage>. <pub-id pub-id-type="doi">10.1021/bi030011f</pub-id>.<pub-id pub-id-type="pmid">12809506</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Aik</surname><given-names>W.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Thalhammer</surname><given-names>A.</given-names></name>; <name><surname>Chowdhury</surname><given-names>R.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2012</year>) <article-title>Role of
the jelly-roll fold in substrate binding by
2-oxoglutarate oxygenases</article-title>. <source>Curr. Opin. Struct.
Biol.</source>
<volume>22</volume>, <fpage>691</fpage>&#x02013;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2012.10.001</pub-id>.<pub-id pub-id-type="pmid">23142576</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Clifton</surname><given-names>I. J.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Ehrismann</surname><given-names>D.</given-names></name>; <name><surname>Kershaw</surname><given-names>N. J.</given-names></name>; <name><surname>Granatino</surname><given-names>N.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2006</year>) <article-title>Structural studies on 2-oxoglutarate oxygenases and
related double-stranded beta-helix fold proteins</article-title>. <source>J. Inorg. Biochem.</source>
<volume>100</volume>, <fpage>644</fpage>&#x02013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2006.01.024</pub-id>.<pub-id pub-id-type="pmid">16513174</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Sekirnik</surname><given-names>R.</given-names></name>; <name><surname>Thalhammer</surname><given-names>A.</given-names></name>; <name><surname>Ge</surname><given-names>W.</given-names></name>; <name><surname>Spivakovsky</surname><given-names>E.</given-names></name>; <name><surname>Mackeen</surname><given-names>M. M.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Cockman</surname><given-names>M. E.</given-names></name>; <name><surname>Kessler</surname><given-names>B. M.</given-names></name>; <name><surname>Ratcliffe</surname><given-names>P. J.</given-names></name>; <name><surname>Wolf</surname><given-names>A.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2014</year>) <article-title>Hydroxylation
of the eukaryotic ribosomal decoding center affects translational
accuracy</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>111</volume>, <fpage>4019</fpage>&#x02013;<lpage>4024</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1311750111</pub-id>.<pub-id pub-id-type="pmid">24550462</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Schofield</surname><given-names>C. J.</given-names></name>; <name><surname>Ratcliffe</surname><given-names>P. J.</given-names></name> (<year>2004</year>) <article-title>Oxygen
sensing by HIF hydroxylases</article-title>. <source>Nat. Rev. Mol.
Cell Biol.</source>
<volume>5</volume>, <fpage>343</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1366</pub-id>.<pub-id pub-id-type="pmid">15122348</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Myllyharju</surname><given-names>J.</given-names></name> (<year>2013</year>) <article-title>Prolyl 4-hydroxylases,
master regulators of the hypoxia response</article-title>. <source>Acta
Physiol.</source>
<volume>208</volume>, <fpage>148</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1111/apha.12096</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Berra</surname><given-names>E.</given-names></name>; <name><surname>Benizri</surname><given-names>E.</given-names></name>; <name><surname>Ginouv&#x000e8;s</surname><given-names>A.</given-names></name>; <name><surname>Volmat</surname><given-names>V.</given-names></name>; <name><surname>Roux</surname><given-names>D.</given-names></name>; <name><surname>Pouyss&#x000e9;gur</surname><given-names>J.</given-names></name> (<year>2003</year>) <article-title>HIF prolyl-hydroxylase
2 is the key oxygen sensor setting
low steady-state levels of HIF-1alpha in normoxia</article-title>. <source>EMBO J.</source>
<volume>22</volume>, <fpage>4082</fpage>&#x02013;<lpage>4090</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdg392</pub-id>.<pub-id pub-id-type="pmid">12912907</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Takeda</surname><given-names>K.</given-names></name>; <name><surname>Cowan</surname><given-names>A.</given-names></name>; <name><surname>Fong</surname><given-names>G. H.</given-names></name> (<year>2007</year>) <article-title>Essential role for prolyl hydroxylase
domain protein 2 in oxygen homeostasis of the adult vascular system</article-title>. <source>Circulation</source>
<volume>116</volume>, <fpage>774</fpage>&#x02013;<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.701516</pub-id>.<pub-id pub-id-type="pmid">17646578</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Hoffart</surname><given-names>L. M.</given-names></name>; <name><surname>Hamed</surname><given-names>R. B.</given-names></name>; <name><surname>Bollinger</surname><given-names>J. M.</given-names><suffix>Jr.</suffix></name>; <name><surname>Krebs</surname><given-names>C.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2010</year>) <article-title>Evidence
for the slow reaction of hypoxia-inducible factor prolyl hydroxylase
2 with oxygen</article-title>. <source>FEBS J.</source>
<volume>277</volume>, <fpage>4089</fpage>&#x02013;<lpage>4099</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07804.x</pub-id>.<pub-id pub-id-type="pmid">20840591</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Gorres</surname><given-names>K. L.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>2010</year>) <article-title>Prolyl 4-hydroxylase</article-title>. <source>Crit. Rev.
Biochem. Mol. Biol.</source>
<volume>45</volume>, <fpage>106</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.3109/10409231003627991</pub-id>.<pub-id pub-id-type="pmid">20199358</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Eriksson</surname><given-names>M.</given-names></name>; <name><surname>Myllyharju</surname><given-names>J.</given-names></name>; <name><surname>Tu</surname><given-names>H.</given-names></name>; <name><surname>Hellman</surname><given-names>M.</given-names></name>; <name><surname>Kivirikko</surname><given-names>K. I.</given-names></name> (<year>1999</year>) <article-title>Evidence
for 4-hydroxyproline in viral proteins. Characterization of a viral
prolyl 4-hydroxylase and its peptide substrates</article-title>. <source>J. Biol. Chem.</source>
<volume>274</volume>, <fpage>22131</fpage>&#x02013;<lpage>22134</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.32.22131</pub-id>.<pub-id pub-id-type="pmid">10428773</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Mecinovi&#x00107;</surname><given-names>J.</given-names></name>; <name><surname>Chowdhury</surname><given-names>R.</given-names></name>; <name><surname>McNeill</surname><given-names>L. A.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2009</year>) <article-title>Evidence
for a stereoelectronic effect in human oxygen
sensing</article-title>. <source>Angew. Chem., Int. Ed.</source>
<volume>48</volume>, <fpage>1784</fpage>&#x02013;<lpage>1787</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200805427</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Bagg</surname><given-names>E. A. L.</given-names></name>; <name><surname>Chowdhury</surname><given-names>R.</given-names></name>; <name><surname>Mecinovi&#x00107;</surname><given-names>J.</given-names></name>; <name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Hewitson</surname><given-names>K. S.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2008</year>) <article-title>Kinetic
rationale for selectivity toward N- and C-terminal oxygen-dependent
degradation domain substrates mediated by a loop region of hypoxia-inducible
factor prolyl hydroxylases</article-title>. <source>J. Biol. Chem.</source>
<volume>283</volume>, <fpage>3808</fpage>&#x02013;<lpage>3815</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M707411200</pub-id>.<pub-id pub-id-type="pmid">18063574</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Kabsch</surname><given-names>W.</given-names></name> (<year>2010</year>) <article-title>XDS</article-title>. <source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>125</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id>.<pub-id pub-id-type="pmid">20124692</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Winn</surname><given-names>M. D.</given-names></name>; <name><surname>Storoni</surname><given-names>L. C.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name> (<year>2007</year>) <article-title>Phaser crystallographic software</article-title>. <source>J. Appl. Crystallogr.</source>
<volume>40</volume>, <fpage>658</fpage>&#x02013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id>.<pub-id pub-id-type="pmid">19461840</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Bunk&#x000f3;czi</surname><given-names>G.</given-names></name>; <name><surname>Chen</surname><given-names>V. B.</given-names></name>; <name><surname>Davis</surname><given-names>I. W.</given-names></name>; <name><surname>Echols</surname><given-names>N.</given-names></name>; <name><surname>Headd</surname><given-names>J. J.</given-names></name>; <name><surname>Hung</surname><given-names>L. W.</given-names></name>; <name><surname>Kapral</surname><given-names>G. J.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>; <name><surname>Oeffner</surname><given-names>R.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>; <name><surname>Richardson</surname><given-names>D. C.</given-names></name>; <name><surname>Richardson</surname><given-names>J. S.</given-names></name>; <name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Zwart</surname><given-names>P. H.</given-names></name> (<year>2010</year>) <article-title>PHENIX: A comprehensive Python-based
system for macromolecular structure solution</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>213</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id>.<pub-id pub-id-type="pmid">20124702</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Lohkamp</surname><given-names>B.</given-names></name>; <name><surname>Scott</surname><given-names>W. G.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name> (<year>2010</year>) <article-title>Features and development
of Coot</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>486</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Chen</surname><given-names>V. B.</given-names></name>; <name><surname>Arendall</surname><given-names>W. B.</given-names></name>; <name><surname>Headd</surname><given-names>J. J.</given-names></name>; <name><surname>Keedy</surname><given-names>D. A.</given-names></name>; <name><surname>Immormino</surname><given-names>R. M.</given-names></name>; <name><surname>Kapral</surname><given-names>G. J.</given-names></name>; <name><surname>Murray</surname><given-names>L. W.</given-names></name>; <name><surname>Richardson</surname><given-names>J. S.</given-names></name>; <name><surname>Richardson</surname><given-names>D. C.</given-names></name> (<year>2010</year>) <article-title>MolProbity: All-atom structure validation
for macromolecular
crystallography</article-title>. <source>Acta Crystallogr., Sect. D:
Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>12</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id>.<pub-id pub-id-type="pmid">20057044</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Joosten</surname><given-names>R. P.</given-names></name>; <name><surname>Long</surname><given-names>F.</given-names></name>; <name><surname>Murshudov</surname><given-names>G. N.</given-names></name>; <name><surname>Perrakis</surname><given-names>A.</given-names></name> (<year>2014</year>) <article-title>The {\it PDB_REDO}
server for macromolecular structure model optimization</article-title>. <source>IUCrJ</source>
<volume>1</volume>, <fpage>213</fpage>&#x02013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1107/S2052252514009324</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Krissinel</surname><given-names>E.</given-names></name>; <name><surname>Henrick</surname><given-names>K.</given-names></name> (<year>2004</year>) <article-title>Secondary-structure matching (SSM), a new tool for
fast protein structure alignment in three dimensions</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>60</volume>, <fpage>2256</fpage>&#x02013;<lpage>2268</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444904026460</pub-id>.<pub-id pub-id-type="pmid">15572779</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>London</surname><given-names>N.</given-names></name>; <name><surname>Raveh</surname><given-names>B.</given-names></name>; <name><surname>Cohen</surname><given-names>E.</given-names></name>; <name><surname>Fathi</surname><given-names>G.</given-names></name>; <name><surname>Schueler-Furman</surname><given-names>O.</given-names></name> (<year>2011</year>) <article-title>Rosetta FlexPepDock
web server--high resolution modeling of peptide-protein interactions</article-title>. <source>Nucleic Acids Res.</source>
<volume>39</volume>, <fpage>W249</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr431</pub-id>.<pub-id pub-id-type="pmid">21622962</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Koski</surname><given-names>M. K.</given-names></name>; <name><surname>Hieta</surname><given-names>R.</given-names></name>; <name><surname>B&#x000f6;llner</surname><given-names>C.</given-names></name>; <name><surname>Kivirikko</surname><given-names>K. I.</given-names></name>; <name><surname>Myllyharju</surname><given-names>J.</given-names></name>; <name><surname>Wierenga</surname><given-names>R. K.</given-names></name> (<year>2007</year>) <article-title>The active site of an algal prolyl
4-hydroxylase has a large structural plasticity</article-title>. <source>J. Biol. Chem.</source>
<volume>282</volume>, <fpage>37112</fpage>&#x02013;<lpage>37123</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M706554200</pub-id>.<pub-id pub-id-type="pmid">17940281</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Biasini</surname><given-names>M.</given-names></name>; <name><surname>Bienert</surname><given-names>S.</given-names></name>; <name><surname>Waterhouse</surname><given-names>A.</given-names></name>; <name><surname>Arnold</surname><given-names>K.</given-names></name>; <name><surname>Studer</surname><given-names>G.</given-names></name>; <name><surname>Schmidt</surname><given-names>T.</given-names></name>; <name><surname>Kiefer</surname><given-names>F.</given-names></name>; <name><surname>Cassarino</surname><given-names>T. G.</given-names></name>; <name><surname>Bertoni</surname><given-names>M.</given-names></name>; <name><surname>Bordoli</surname><given-names>L.</given-names></name>; <name><surname>Schwede</surname><given-names>T.</given-names></name> (<year>2014</year>) <article-title>SWISS-MODEL: Modelling
protein tertiary and quaternary structure using evolutionary information</article-title>. <source>Nucleic Acids Res.</source>
<volume>42</volume>, <fpage>W252</fpage>&#x02013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku340</pub-id>.<pub-id pub-id-type="pmid">24782522</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Arnold</surname><given-names>K.</given-names></name>; <name><surname>Bordoli</surname><given-names>L.</given-names></name>; <name><surname>Kopp</surname><given-names>J.</given-names></name>; <name><surname>Schwede</surname><given-names>T.</given-names></name> (<year>2006</year>) <article-title>The SWISS-MODEL workspace:
A web-based environment for protein structure homology modelling</article-title>. <source>Bioinformatics</source>
<volume>22</volume>, <fpage>195</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti770</pub-id>.<pub-id pub-id-type="pmid">16301204</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Hess</surname><given-names>B.</given-names></name>; <name><surname>Kutzner</surname><given-names>C.</given-names></name>; <name><surname>Van Der Spoel</surname><given-names>D.</given-names></name>; <name><surname>Lindahl</surname><given-names>E.</given-names></name> (<year>2008</year>) <article-title>GRGMACS 4: Algorithms
for highly efficient, load-balanced, and scalable molecular simulation</article-title>. <source>J. Chem. Theory Comput.</source>
<volume>4</volume>, <fpage>435</fpage>&#x02013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1021/ct700301q</pub-id>.<pub-id pub-id-type="pmid">26620784</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Van
Der Spoel</surname><given-names>D.</given-names></name>; <name><surname>Lindahl</surname><given-names>E.</given-names></name>; <name><surname>Hess</surname><given-names>B.</given-names></name>; <name><surname>Groenhof</surname><given-names>G.</given-names></name>; <name><surname>Mark</surname><given-names>A. E.</given-names></name>; <name><surname>Berendsen</surname><given-names>H. J. C.</given-names></name> (<year>2005</year>) <article-title>GROMACS: Fast, flexible, and free</article-title>. <source>J. Comput. Chem.</source>
<volume>26</volume>, <fpage>1701</fpage>&#x02013;<lpage>1718</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20291</pub-id>.<pub-id pub-id-type="pmid">16211538</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Oostenbrink</surname><given-names>C.</given-names></name>; <name><surname>Villa</surname><given-names>A.</given-names></name>; <name><surname>Mark</surname><given-names>A. E.</given-names></name>; <name><surname>Van Gunsteren</surname><given-names>W. F.</given-names></name> (<year>2004</year>) <article-title>A biomolecular
force field based on the free enthalpy of hydration and solvation:
The GROMOS force-field parameter sets 53A5 and 53A6</article-title>. <source>J. Comput. Chem.</source>
<volume>25</volume>, <fpage>1656</fpage>&#x02013;<lpage>1676</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20090</pub-id>.<pub-id pub-id-type="pmid">15264259</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Zheng</surname><given-names>H.</given-names></name>; <name><surname>Chordia</surname><given-names>M. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. R.</given-names></name>; <name><surname>Chruszcz</surname><given-names>M.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>P.</given-names></name>; <name><surname>Sheldrick</surname><given-names>G. M.</given-names></name>; <name><surname>Minor</surname><given-names>W.</given-names></name> (<year>2013</year>) <article-title>Validation of metal-binding sites
in macromolecular structures with the CheckMyMetal web server</article-title>. <source>Nat. Protoc.</source>
<volume>9</volume>, <fpage>156</fpage>&#x02013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2013.172</pub-id>.<pub-id pub-id-type="pmid">24356774</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Chowdhury</surname><given-names>R.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Mecinovi&#x00107;</surname><given-names>J.</given-names></name>; <name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Hewitson</surname><given-names>K. S.</given-names></name>; <name><surname>Domene</surname><given-names>C.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2009</year>) <article-title>Structural
basis for binding of hypoxia-inducible factor to the oxygen-sensing
prolyl hydroxylases</article-title>. <source>Structure</source>
<volume>17</volume>, <fpage>981</fpage>&#x02013;<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2009.06.002</pub-id>.<pub-id pub-id-type="pmid">19604478</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Koski</surname><given-names>M. K.</given-names></name>; <name><surname>Hieta</surname><given-names>R.</given-names></name>; <name><surname>Hirsil&#x000e4;</surname><given-names>M.</given-names></name>; <name><surname>R&#x000f6;nk&#x000e4;</surname><given-names>A.</given-names></name>; <name><surname>Myllyharju</surname><given-names>J.</given-names></name>; <name><surname>Wierenga</surname><given-names>R. K.</given-names></name> (<year>2009</year>) <article-title>The crystal structure
of an algal
prolyl 4-hydroxylase complexed with a proline-rich peptide reveals
a novel buried tripeptide binding motif</article-title>. <source>J.
Biol. Chem.</source>
<volume>284</volume>, <fpage>25290</fpage>&#x02013;<lpage>25301</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.014050</pub-id>.<pub-id pub-id-type="pmid">19553701</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Lu</surname><given-names>Z.</given-names></name>; <name><surname>Burbank</surname><given-names>D. E.</given-names></name>; <name><surname>Kutish</surname><given-names>G. F.</given-names></name>; <name><surname>Rock</surname><given-names>D. L.</given-names></name>; <name><surname>Van Etten</surname><given-names>J. L.</given-names></name> (<year>1995</year>) <article-title>Analysis
of 43 kb of the Chlorella Virus PBCV-1 330-kb Genome: Map Positions
45 to 88</article-title>. <source>Virology</source>
<volume>212</volume>, <fpage>134</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1006/viro.1995.1462</pub-id>.<pub-id pub-id-type="pmid">7676624</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Li</surname><given-names>V.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Chowdhury</surname><given-names>R.</given-names></name>; <name><surname>Mohr</surname><given-names>C.</given-names></name>; <name><surname>Li&#x000e9;nard</surname><given-names>B. M. R.</given-names></name>; <name><surname>Zondlo</surname><given-names>J.</given-names></name>; <name><surname>Oldham</surname><given-names>N. J.</given-names></name>; <name><surname>Clifton</surname><given-names>I. J.</given-names></name>; <name><surname>Lewis</surname><given-names>J.</given-names></name>; <name><surname>McNeill</surname><given-names>L. A.</given-names></name>; <name><surname>Kurzeja</surname><given-names>R. J. M.</given-names></name>; <name><surname>Hewitson</surname><given-names>K. S.</given-names></name>; <name><surname>Yang</surname><given-names>E.</given-names></name>; <name><surname>Jordan</surname><given-names>S.</given-names></name>; <name><surname>Syed</surname><given-names>R. S.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2006</year>) <article-title>Cellular
oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl
hydroxylase (PHD2)</article-title>. <source>Proc. Natl. Acad. Sci. U.
S. A.</source>
<volume>103</volume>, <fpage>9814</fpage>&#x02013;<lpage>9819</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0601283103</pub-id>.<pub-id pub-id-type="pmid">16782814</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Culpepper</surname><given-names>M. A.</given-names></name>; <name><surname>Scott</surname><given-names>E. E.</given-names></name>; <name><surname>Limburg</surname><given-names>J.</given-names></name> (<year>2010</year>) <article-title>Crystal structure of prolyl 4-hydroxylase
from Bacillus anthracis</article-title>. <source>Biochemistry</source>
<volume>49</volume>, <fpage>124</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1021/bi901771z</pub-id>.<pub-id pub-id-type="pmid">19947658</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Scotti</surname><given-names>J. S.</given-names></name>; <name><surname>Leung</surname><given-names>I. K. H.</given-names></name>; <name><surname>Ge</surname><given-names>W.</given-names></name>; <name><surname>Bentley</surname><given-names>M. A.</given-names></name>; <name><surname>Paps</surname><given-names>J.</given-names></name>; <name><surname>Kramer</surname><given-names>H. B.</given-names></name>; <name><surname>Lee</surname><given-names>J.</given-names></name>; <name><surname>Aik</surname><given-names>W.</given-names></name>; <name><surname>Choi</surname><given-names>H.</given-names></name>; <name><surname>Paulsen</surname><given-names>S. M.</given-names></name>; <name><surname>Bowman</surname><given-names>L. A. H.</given-names></name>; <name><surname>Loik</surname><given-names>N. D.</given-names></name>; <name><surname>Horita</surname><given-names>S.</given-names></name>; <name><surname>Ho</surname><given-names>C.</given-names></name>; <name><surname>Kershaw</surname><given-names>N. J.</given-names></name>; <name><surname>Tang</surname><given-names>C. M.</given-names></name>; <name><surname>Claridge</surname><given-names>T. D. W.</given-names></name>; <name><surname>Preston</surname><given-names>G. M.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2014</year>) <article-title>Human oxygen sensing may have origins
in prokaryotic elongation factor Tu prolyl-hydroxylation</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>111</volume>, <fpage>13331</fpage>&#x02013;<lpage>13336</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1409916111</pub-id>.<pub-id pub-id-type="pmid">25197067</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Horita</surname><given-names>S.</given-names></name>; <name><surname>Scotti</surname><given-names>J. S.</given-names></name>; <name><surname>Thinnes</surname><given-names>C.</given-names></name>; <name><surname>Mottaghi-Taromsari</surname><given-names>Y. S.</given-names></name>; <name><surname>Thalhammer</surname><given-names>A.</given-names></name>; <name><surname>Ge</surname><given-names>W.</given-names></name>; <name><surname>Aik</surname><given-names>W.</given-names></name>; <name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name>; <name><surname>McDonough</surname><given-names>M. A.</given-names></name> (<year>2015</year>) <article-title>Structure of the Ribosomal Oxygenase
OGFOD1 Provides Insights into the Regio- and Stereoselectivity of
Prolyl Hydroxylases</article-title>. <source>Structure</source>
<volume>23</volume>, <fpage>639</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2015.01.014</pub-id>.<pub-id pub-id-type="pmid">25728928</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Henri</surname><given-names>J.</given-names></name>; <name><surname>Rispal</surname><given-names>D.</given-names></name>; <name><surname>Bayart</surname><given-names>E.</given-names></name>; <name><surname>Van Tilbeurgh</surname><given-names>H.</given-names></name>; <name><surname>S&#x000e9;raphin</surname><given-names>B.</given-names></name>; <name><surname>Graille</surname><given-names>M.</given-names></name> (<year>2010</year>) <article-title>Structural and functional
insights
into Saccharomyces cerevisiae Tpa1, a putative prolylhydroxylase influencing
translation termination and transcription</article-title>. <source>J.
Biol. Chem.</source>
<volume>285</volume>, <fpage>30767</fpage>&#x02013;<lpage>30778</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.106864</pub-id>.<pub-id pub-id-type="pmid">20630870</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>McNeill</surname><given-names>L. A.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Buck</surname><given-names>M. R. G.</given-names></name>; <name><surname>Hewitson</surname><given-names>K. S.</given-names></name>; <name><surname>Clifton</surname><given-names>I. J.</given-names></name>; <name><surname>Jeschke</surname><given-names>G.</given-names></name>; <name><surname>Claridge</surname><given-names>T. D. W.</given-names></name>; <name><surname>Ehrismann</surname><given-names>D.</given-names></name>; <name><surname>Oldham</surname><given-names>N. J.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2005</year>) <article-title>Hypoxia-inducible factor prolyl hydroxylase
2 has a high affinity for ferrous iron and 2-oxoglutarate</article-title>. <source>Mol. BioSyst.</source>
<volume>1</volume>, <fpage>321</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1039/b511249b</pub-id>.<pub-id pub-id-type="pmid">16880998</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Tarhonskaya</surname><given-names>H.</given-names></name>; <name><surname>Chowdhury</surname><given-names>R.</given-names></name>; <name><surname>Leung</surname><given-names>I. K. H.</given-names></name>; <name><surname>Loik</surname><given-names>N. D.</given-names></name>; <name><surname>McCullagh</surname><given-names>J. S. O.</given-names></name>; <name><surname>Claridge</surname><given-names>T. D. W.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name> (<year>2014</year>) <article-title>Investigating the contribution of the active site environment
to the slow reaction of hypoxia-inducible factor prolyl hydroxylase
domain 2 with oxygen</article-title>. <source>Biochem. J.</source>
<volume>463</volume>, <fpage>363</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20140779</pub-id>.<pub-id pub-id-type="pmid">25120187</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Clifton</surname><given-names>I. J.</given-names></name>; <name><surname>Doan</surname><given-names>L. X.</given-names></name>; <name><surname>Sleeman</surname><given-names>M. C.</given-names></name>; <name><surname>Topf</surname><given-names>M.</given-names></name>; <name><surname>Suzuki</surname><given-names>H.</given-names></name>; <name><surname>Wilmouth</surname><given-names>R. C.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2003</year>) <article-title>Crystal
structure of carbapenem synthase
(CarC)</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>20843</fpage>&#x02013;<lpage>20850</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M213054200</pub-id>.<pub-id pub-id-type="pmid">12611886</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Wilmouth</surname><given-names>R. C.</given-names></name>; <name><surname>Turnbull</surname><given-names>J. J.</given-names></name>; <name><surname>Welford</surname><given-names>R. W. D.</given-names></name>; <name><surname>Clifton</surname><given-names>I. J.</given-names></name>; <name><surname>Prescott</surname><given-names>A. G.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2002</year>) <article-title>Structure
and mechanism of anthocyanidin synthase from
Arabidopsis thaliana</article-title>. <source>Structure</source>
<volume>10</volume>, <fpage>93</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-2126(01)00695-5</pub-id>.<pub-id pub-id-type="pmid">11796114</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Ren</surname><given-names>J.-s.</given-names></name>; <name><surname>Harlos</surname><given-names>K.</given-names></name>; <name><surname>McKinnon</surname><given-names>C. H.</given-names></name>; <name><surname>Clifton</surname><given-names>I. J.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name> (<year>2002</year>) <article-title>Crystal
structure of a clavaminate synthase-Fe(II)-2-oxoglutarate-substrate-NO
complex: evidence for metal centered rearrangements</article-title>. <source>FEBS Lett.</source>
<volume>517</volume>, <fpage>7</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(02)02520-6</pub-id>.<pub-id pub-id-type="pmid">12062399</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Price</surname><given-names>J. C.</given-names></name>; <name><surname>Barr</surname><given-names>E. W.</given-names></name>; <name><surname>Hoffart</surname><given-names>L. M.</given-names></name>; <name><surname>Krebs</surname><given-names>C.</given-names></name>; <name><surname>Bollinger</surname><given-names>J. M.</given-names></name> (<year>2005</year>) <article-title>Kinetic
dissection of the catalytic mechanism of taurine:alpha-ketoglutarate
dioxygenase (TauD) from Escherichia coli</article-title>. <source>Biochemistry</source>
<volume>44</volume>, <fpage>8138</fpage>&#x02013;<lpage>8147</lpage>. <pub-id pub-id-type="doi">10.1021/bi050227c</pub-id>.<pub-id pub-id-type="pmid">15924433</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Bleijlevens</surname><given-names>B.</given-names></name>; <name><surname>Shivarattan</surname><given-names>T.</given-names></name>; <name><surname>van den Boom</surname><given-names>K. S.</given-names></name>; <name><surname>de Haan</surname><given-names>A.</given-names></name>; <name><surname>van der
Zwan</surname><given-names>G.</given-names></name>; <name><surname>Simpson</surname><given-names>P. J.</given-names></name>; <name><surname>Matthews</surname><given-names>S. J.</given-names></name> (<year>2012</year>) <article-title>Changes in protein dynamics of the
DNA repair dioxygenase AlkB upon binding of Fe(2+) and 2-oxoglutarate</article-title>. <source>Biochemistry</source>
<volume>51</volume>, <fpage>3334</fpage>&#x02013;<lpage>3341</lpage>. <pub-id pub-id-type="doi">10.1021/bi201699e</pub-id>.<pub-id pub-id-type="pmid">22443471</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Bleijlevens</surname><given-names>B.</given-names></name>; <name><surname>Shivarattan</surname><given-names>T.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name>; <name><surname>Yang</surname><given-names>Y.</given-names></name>; <name><surname>Simpson</surname><given-names>P. J.</given-names></name>; <name><surname>Koivisto</surname><given-names>P.</given-names></name>; <name><surname>Sedgwick</surname><given-names>B.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name>; <name><surname>Matthews</surname><given-names>S. J.</given-names></name> (<year>2008</year>) <article-title>Dynamic states of the DNA repair enzyme AlkB regulate
product release</article-title>. <source>EMBO Rep.</source>
<volume>9</volume>, <fpage>872</fpage>&#x02013;<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2008.120</pub-id>.<pub-id pub-id-type="pmid">18617893</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Stubbs</surname><given-names>C. J.</given-names></name>; <name><surname>Loenarz</surname><given-names>C.</given-names></name>; <name><surname>Mecinovi&#x00107;</surname><given-names>J.</given-names></name>; <name><surname>Yeoh</surname><given-names>K. K.</given-names></name>; <name><surname>Hindley</surname><given-names>N.</given-names></name>; <name><surname>Li&#x000e9;nard</surname><given-names>B. M.</given-names></name>; <name><surname>Sobott</surname><given-names>F.</given-names></name>; <name><surname>Schofield</surname><given-names>C. J.</given-names></name>; <name><surname>Flashman</surname><given-names>E.</given-names></name> (<year>2009</year>) <article-title>Application of a proteolysis/mass
spectrometry method
for investigating the effects of inhibitors on hydroxylase structure</article-title>. <source>J. Med. Chem.</source>
<volume>52</volume>, <fpage>2799</fpage>&#x02013;<lpage>2805</lpage>. <pub-id pub-id-type="doi">10.1021/jm900285r</pub-id>.<pub-id pub-id-type="pmid">19364117</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Flagg</surname><given-names>S. C.</given-names></name>; <name><surname>Giri</surname><given-names>N.</given-names></name>; <name><surname>Pektas</surname><given-names>S.</given-names></name>; <name><surname>Maroney</surname><given-names>M. J.</given-names></name>; <name><surname>Knapp</surname><given-names>M. J.</given-names></name> (<year>2012</year>) <article-title>Inverse
solvent isotope effects demonstrate slow aquo release from hypoxia
inducible factor-prolyl hydroxylase (PHD2)</article-title>. <source>Biochemistry</source>
<volume>51</volume>, <fpage>6654</fpage>&#x02013;<lpage>6666</lpage>. <pub-id pub-id-type="doi">10.1021/bi300229y</pub-id>.<pub-id pub-id-type="pmid">22747465</pub-id></mixed-citation></ref></ref-list></back></article>